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Abstract
HIV/AIDS, a sexually transmitted diseases continues to affect the lives of millions
of individuals worldwide. This retrovirus targets CD4 T-cell populations, the main
driver of the immune system by using the chemokine co-receptor 5 (CCR5). Despite
the success of the highly active antiretroviral therapy in reconstituting the immune
system, HIV infected individuals still suffer from low CD4 T-cell counts. Recently,
researchers were able to highlight the success of immunotherapy in restoring the
CD4 T-cell count. To further, investigate such importance, our collaborators at
case Western University injected CCR5-down-modulated memory CD4 T-cells into
9 chronically infected HIV patients. Using a linear transitions from the naive to the
effector memory state, a non linear ordinary differential equation model was used to
model the experiment. Various data fitting techniques in Matlab Stan and Monolix
software were used to estimate the model parameters (proliferation, death, transition
and birth rates) before and after the initiation of the treatment to study the change
of the cell dynamics. Our fittings have indicated an increase in the memory stem
ii
and na¨ıve cell lifespan post-clinical trial. Using sensitivity analysis, we showed that
the na¨ıve cell birth rate from the thymus λ, the memory stem cell proliferation
rate pST and the central memory cell death rate dC played an important role in
restoring the CD4 T-cell count. A stochastic model for the CD4 T-cells population
was developed to examine if fluctuations from the stochastic simulation were able to
capture the experimental data measurements. The findings of this study indicates
the importance of looking further into how modified CD4 T-cells are able to restore
the T-cell counts which thereby decrease the HIV virus pool and help HIV patients
to maintain a low level of the virus and most importantly a high level of T-cell
count.
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1 Introduction
Mathematical Modeling of infectious disease has become a growing area in the
past two centuries. This is because infectious diseases are the number one cause of
human morbidity in the world [9]. This discipline has helped to gain insights about
the dynamics of infectious diseases on both population and in-host levels. Some of
the most important advantages of using mathematical models, its ability to analyze
and unfold unobserved dynamics experimentally.
Mathematical immunology studies the spread of the disease in the host by analyzing
the interaction between the immune cells and the pathogens. This field stemmed in
the early 1980’s with the emergence of the Human Immunodeficiency Virus(HIV)
pandemic [15]. One of the primary reasons for the success in this area is the ability
for researchers to collect experimental data and use it in the mathematical models
to draw important conclusions about the dynamics of the immune system, the virus
and the effect of vaccines and other drug treatments. Many great mathematicians
have elaborated on this area such as Perleson, Nowak and May and others [16,17,18].
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These models were mainly used to study the dynamics of the HIV and the immune
system in the presence of the virus in the body. Some of the most remarkable
findings that corrected our understanding about the HIV dynamics in the body of
chronically infected individuals were achieved by Georges et al [17] and Perleson et
al in 1995 [30]. Using experimental data measurements, they were able to show that
in the chronic infection stage, the CD4 T-cell count is constant as a result of an
interesting immune system dynamics where millions of the CD4 T-cells are being
killed but replaced daily by the thymus. However, a great amount of mathematicians
have and are applying these models to other diseases but not limited to: measles [19],
hepatitis B and C [21], flu [22] and HPV [20]. Besides studying disease dynamics,
mathematical immunology was used to study B and T-cells dynamics[23]. Most of
mathematical models used in epidemiology and immunology consisted of coupled
ordinary differential equations (ODEs). Despite the success of using ODE models,
many researchers have started using stochastic models due to its ability to account
for stochasticity in the disease dynamic unlike the deterministic models [14]. As
mentioned above, mathematical models have shed light on various processes in HIV
infection, including effective drug therapy regimens [25], activation of the immune
system [28], and latently infected cells [27]. Some researchers have focused on
studying the dynamic of memory CD4 T-cells in HIV infected individuals [24,26].
A recent clinical study by Sekaly et al at Case Western has determined that
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introducing a dose of CCR5-down- modulated memory CD4 T-cells is able to induce
the activity of the immune cell in chronically infected HIV patients. Hence the work
of this thesis will focus on modeling this experimental trial in order to quantify the
resulting immune system dynamics after the introduction of such perturbation to
the CD4 T-cell population.
In the sections below, I will elaborate more about the immune system, disease, its
structure, transmission and progression to AIDS. In addition, I will present the
previous models used to study the HIV-immune system dynamics. Deterministic
and stochastic models are both considered. Later, I will describe the clinical trial
performed by our collaborators (Sekaly et al., 2013). Lastly, I will describe the
longitudinal data of the three cohorts that was obtained from the study [52].
1.1 Basic Facts About the Immune System
The immune system is among one of the most important systems in the human
bodies that sustains survival [5]. The understanding of its function began in the 19th
century and up to date some aspects of the immune system remains unclear [5]. The
immune system consists of a variety of cells, organs and tissues that work collectively
in order to fight any foreign organisms such as bacteria, viruses and fungus that
poses a threat to the host. The immune system distinct any foreign organisms by
identifying two patterns called Danger or Pathogen -Associated- molecular patterns,
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also known as DAMPs and PAMPs [5]. It is composed of two major responses;
the Innate and Adaptive response. These responses are distinguished based on
the components, activity, response time, duration and the ability to build memory
against a specific pathogen. As the Adaptive immune system is our main focus in
this paper, we will not be discussing the details about the Innate immune response.
Briefly, the innate immune response is mainly composed of macrophages, white blood
cells and natural killer cells. The innate immune responses is fast and unspecific as
these cells act directly on any pathogen once it is recognized. It is activated within
hours of the foreign pathogen’s discovery [1,5].
In many cases the innate immune response is enough to contain an infection, however
in some cases it gets overwhelmed by the rapid replication of some viruses as in
the case of HIV infection. In this case the acquired immune system gets activated.
It is known as acquired because this immunity is built from previous exposure to
pathogens (bacteria and viruses), vaccinations or maternal immunity. This response
could take days or weeks to be activated and it is known to be specific, where the
presence of Antigen Presenting cells (APCs) is required for activation. There exist
two types of adaptive immune systems responses; The humoral and cell-mediated
responses. Both are carried out by two classes of white blood cells also known as
lymphocytes [1]. The mediated immune system is composed of T-cells, which are
produced in the bone marrow and is responsible for killing infected cells. However
4
these cells mature in the Thymus either to contribute to lymphocyte maturation
or kill infected cells [1]. There exist two types of T-cells; CD4 or helper T-cell and
CD8 or cytotoxic lymphocyte T-cells, depending on the receptor present on the cell
surface. Once activated by the antigen presented by the MHCII on the macrophage
cell surface, the helper T-cells are activated and produce cytokines. The cytokines
activate the B-cells and the production of CD8 T-cells that are responsible in killing
infected cells. The main focus of this thesis are the na¨ıve and memory CD4 T-cell
population.
B-cells are produced and mature in the bone marrow. These cells compose the
humoral immune response where they bind to antigen to produce the right antibodies.
Later, these antibodies are used to kill free viruses and bacteria. The activation
process of the B and T-cells is illustrated in Figure 1.1.
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Figure 1.1: Activation process of B and T- cells.
In this figure the activation process of the T and B cells upon infection is
illustrated. First the macrophage engulfs the virus where the MHCII presents the
antigen on the macrophage cell surface. The na¨ıve helper T-cells receptors binds to
the MHCII-Antigen complex. This step activates the helper T-cells and cytokines
are secreted. The secretion of the cytokines activates the B cells and produces CD8
or cytotoxic T-cell. The immune system is then activated.
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1.1.1 CD4 T-cells
One of the most important feature of the immune system is the ability to develop
memory against any pathogen. They are shown to have an imperative role in the
adaptive immune response to infectious disease [7]. These memory cells have been
the main focus of researchers when designing vaccines [3]. A study conducted by
(STEVEN M. SCHNITTMAN et al., 1990) showed the HIV-1 virus preferentially
infect memory CD4 T-cells subsets.
CD4 T-cells are divided into two kind of cells: memory and na¨ıve [28]. After being
exposed to antigen, the na¨ıve T-cells proliferate and differentiate to memory CD4 T-
cells if able to survive the contraction phase [7]. Memory CD4 T-cells are composed
of 4 subsets, where the na¨ıve CD4 T-cells transition to the memory effector state
[6]. It is still not clear how the transition from the na¨ıve to the memory effector
state occurs in the body. However, in this paper will follow the model proposed
by (Mahnke et al., 2013) and our experimental collaborator (Sekaly et al.) where
a linear transition from the na¨ıve state to effector memory state is considered as
illustrated in Figure 1.2 below.
• Na¨ıve cells: These cells are produced by the thymus. No Antigen and marker
of cellular, activation is expressed on the cell surface [5,6].
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• Memory stem cells: It is the first subsets of memory T-cells that expresses
stem like property with having a na¨ıve phenotype. These cells cannot be made
by any other memory T cell subset [3]. It was found that these cells have
a higher rate of survival and proliferation compared to the na¨ıve and other
subsets of memory T-cells [7].
• Central memory cells: These cells are produced by the stem memory cells.
They circulate primarily between the blood and lymphs.
• Transitional memory cells: It was shown to be located in the peripheral blood.
These cells have a higher proliferation rate than TCM cells [6].
• Effector memory cells: It was shown that these cells are short lived[8]. They
express effector phenotype such as cytokines secretion faster than the other
CD4 memory subsets. They move from the blood to peripheral tissues [8].
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Figure 1.2: The Transition of CD4 T-cells from na¨ıve to effector memory state.
In this figure the transition from na¨ıve to effector memory cells is illustrated.
Where the expression of CCR5 increases gradually moving from the na¨ıve to the
effector state [7].
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1.2 Human Immunodeficiency Virus-HIV
1.2.1 Pandemic
HIV, is a sexually transmitted disease. The virus is classified as a Retrovirus
and belongs to the family of lentivirinae that is characterized by its long incubation
period. There exist two types of HIV : HIV-1 and HIV-2. Even though both of
these types will progress to the Acquired immunodeficiency syndrome(AIDS) stage,
each has its own origin, biological and molecular characterizations [4]. The first
HIV condition reported to the public in 1980,in New York and San Francisco in
the homosexual community where rare cancer cases such as Kaposi’s sacroma were
observed among young individuals. Few months later, the disease was reported in
the intravenous drug users communities as well as in hemophiliacs and heterosexuals
partners[4]. Soon HIV became a serious epidemic. Since the discovery of the first
case, at the end of 2014 approximately 36.9 million individuals are currently living
with HIV [2]. According to the WHO, since its discovery, AIDS-related disease
have caused the death of over 34 million people up to date[2]. The majority of
the affected individuals are from low income countries, where Sub-Saharan Africa
accounts for more than 70 percent of the cases as illustrated in Figure 1.3 [2]. Since
the discovery of the disease, a tremendous amount of research have focused on
better understanding the emergence, spread of the disease and most importantly
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its unique pathogencity with the intention of developing a potential vaccine or a cure.
Figure 1.3: Number of people Living with HIV by Region in 2014
This figure illustrates the proportion of reported HIV positive cases worldwide per
region. It is evident that Sub Saharan Africa account for more than 70 % of the
cases in the world. This figure was adapted from avert 2014 statistics, [32].
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1.2.2 Transmission and Progression
HIV transmission is sensitive to the amount of free virions and the degree of
contact upon exposure. It has been shown that the virus has a high concentration
of free virons in the blood stream and the genital fluids. Therefore, HIV can
only be transmitted by the exchange of blood or body fluids such as semen and
vaginal fluids from an infected individual. Sexual activities account for almost 75
percent of all new HIV cases [4]. In addition, HIV could be passed on by the use
of unsterile needles in cases of blood transfusion or drug users. A mother could
pass HIV to her fetus/baby during or after delivery as well as during breast feeding.
However the degree of transmission depends on the stage of the infection. Early
HIV phase yields a higher concentration of free virons in the breast milk which
leads to a higher chance of transmission [4]. As the saliva contains glycoproteins
and fibronectins it is thought to inhibit the cell to cell transfer of virus, saliva, tears
sweat and faeces have low virions level and cannot be a mode of HIV transmission [4].
1.2.3 Structure
HIV consists of an outer membrane which consists of two layers of lipids proteins;
gp120 and gp41, these lipid proteins are uniformly arranged into 72 knobs [4]. The
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Glycoprotein 120 is located on the outer membrane of the virus and gp41 is embedded
in the lipid matrix. As HIV is a retrovirus, it stores its two copies of ribonucleic acid,
also known as RNA, in the inner core used to encode the necessary viral proteins
for maturation. Along with the RNA, it contains three enzymes; reverse transcrip-
tase, integrase and protease which plays a primary role in the viral replication and
maturation process. In addition, it contains the protein of the last host cell that has
infected previously[4]. Figure 1.4 illustrates in more details the structure of the virus.
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Figure 1.4: Structure of the HIV.
HIV is a retrovirus where it contains 2 copies of RNA and 3 essential enzymes. An
outer membrane consisting of gp120 and gp 41. This virus uses the host cells such
as CD4 T-cell to replicate. This Figure was adapted from [34].
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1.2.4 Life-Cycle
Like any other virus, HIV needs a host cell in order to replicate. When HIV
succeed to enter the human body, its main target is to replicate by infecting one
kind of the immune system cells that has CD4 receptors on the surface. Figure 1.5
illustrates the 3 major steps of the replication process.
(1) Binding/ Fusion with the CD4-T cells
The first stage of the process is when the HIV binds itself to the CD4 T cells. This
is accomplished by the binding of the gp120 glycoprotein to the CD4 receptors.
Later, the transmembrane gp41 binds to the co-receptor CCR5 or CCRX4 present
on the CD4-T cells. This binding causes a conformational change which allows the
fusion of the cell-virus membranes. Once it is fused, the viral nucleocapside enters
the cells and releases the two copies of the RNA along with three enzymes essential
for the viral replication.
(2) Transcription and Translation
Once inside the cell, the reverse transcriptase begins the transcription of the single
stranded viral RNA into a double helix DNA. Later, the viral DNA enters the host
cell’s nucleus where it is integrated to its DNA by the integrase enzyme. Now the
virus genetic material are embedded in the CD4 T- cells DNA. Two possible events
could occur. First, if the infected CD4 T-cell is activated, proviral DNA will be
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transcribed into messenger RNA. Then the mRNA moves to the cytoplasm where it
is translated into essential viral proteins. Otherwise, if not activated, the infected
cells remains latent.
(3) Maturation and Budding
Once the mRNA is fully translated into viral proteins, the protease enzymes cleaves
the long strains of proteins. This is an essential step for the HIV maturation as
some of these proteins becomes enzymes and others turn into structural elements.
Once the viral elements are assembled, it buds off the cell and a new virus is created
and ready to infect other CD4 T-cells.
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Figure 1.5: HIV Viral Life-cycle.
HIV viral Life-cycle is divided into three major steps: First the binding and fusing
of the HIV and CD4 T-cell occurs. Once inside the virus begins its transcription
and translation process to embed a copy of the viral DNA into the host DNA. Once
the mRNA is translated, the virus buds and a new mature virus is released.This
figure was adapted from [57].
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1.2.5 Treatment
Since the emergence of HIV, various drugs have been introduced to target several
important steps in the virus infection life-cycle. These drugs are used to slow down
the progression to AIDS by making the viral load low enough to be considered
undetectable. As shown in Figure 1.6, the number of deaths associated with HIV
has decreased upon the introduction of the drugs in the early 1990’s. The decrease
in the number of death is associated with the increase of the number of people
living with HIV. However, these drugs are not equally available to all individuals
especially those infected in third world countries such as Africa. Below is the list of
different classes of antiretroviral drugs:
• Protease Inhibitor, also known as PI’s. This class of drugs inhibits the function
of the protease enzyme. This inhibition prevents the budding of the newly
made virions.
• Integrase Inhibitor, inhibits the function of the integrase enzyme so the viral
DNA is not integrated into the host cell’s DNA.
• Fusion inhibitor, these medication inhibits the the fusion between the virus
and the CD4 T-cells. However, this class of drugs have proven to be not very
effective in blocking the CD4 T-cell and preventing fusion.
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• Reverse transcriptase Inhibitor, prevents the viral RNA from being transcribed
into DNA. This will later stop the lifecycle as the virus does not have the
DNA to incorporate in the host cell and begin the replication process.
HAART ( Highly Active Anti-Retroviral Therapy), is a cocktail of 3 or more
of the drug classes mentioned above. The main reason behind this cocktail is to
reduce the emergence of mutated HIV types that are resistant to the drugs. Despite
the effort of the drugs, mutations are highly likely to occur in the infection lifetime
of a patient. However, we will not be considering the possible mutations throughout
this work.
As this is a lifetime therapy, these drugs have various health effects on the human
body, which leaves the patients in poor health conditions at times. Hence in this
work we are trying to understand the effectiveness of using the immunotherapy
approach in order to reconstitute the total CD4 T-cell count.
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Figure 1.6: Number of Death and HIV positive individual in US from the period
before and After the introduction of HAART.
The number of death and poeple living with HIV in US from 1981-2007. In this
graph it is shows that when the HAART was introduced the number of death
decreased and the number of people living with HIV increased as a result. This
figure was adapted from [35].
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1.3 Modeling HIV and Immune system
Since the discovery of the disease, a tremendous amount of research have focused
on better understanding the emergence, spread of the disease and most importantly
its unique pathogencity with the intention of developing a potential vaccine or
a cure. Over the past two decades, thousands of studies were published about
HIV/AIDS[29]. Many of those studies used statistical, deterministic and stochastic
mathematical models to study the disease dynamics [29]. These models have made
great advancements in better understanding epidemiological and immunological
aspects of the virus. Some of the most important early works were done by A.
Perelson and D. Ho. They used clinical data from HIV positive individuals to study
the dynamics of HIV and T-cells in the absence and presence of antiviral drug
therapies [30,31].
These studies have mainly focused on using ordinary differential equations to model
such dynamics. These compartmental models are used to examine the interactions
between several classes of populations to study and predict the changes in each of
the population size over a certain time period. This is accomplished by representing
the rate of change in these populations using ODEs. Any of the population size
could be estimated by solving these differential equations at a specific time point.
The basic ODE model for describing the HIV-immune system interaction is composed
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of three compartments; the uninfected T-cell, the infected T-cells and the free HIV
virions particles. This model was used in several papers such as [30,31,25]. Using
the basic model, researchers were able to draw some important conclusions about
the viral clearance rate, the lifespan of the infected T-cells and the viral production
rate from each infected cell [38,39]. The Basic model is illustrated in the system of
ODEs Eq’s 1.1, where λ is the birth rate of uninfected cell, d and a are the death
rates of the infected and uninfected immune cells respectively, k is the virus bud
rate and u is the virus clearing rate.
x′ = λ− dx− βxy (1.1)
y′ = βxy − ay
v′ = ky − uv
Still the simplicity of this basic model was not enough to study various important
dynamics such as the HIV mutation strains, the effect of the antiretroviral drug and
so on, so extensions to the basic model are formulated. These models were able to
better understand the role of the antiretroviral drug in blocking and slowing down
the HIV infection process [17,18]. This was achieved by adding extra parameters 1
and  to the basic model to illustrate the inhibition of both the reverse transcriptase
and protease inhibitors correspondingly. A factor of (1-1) and (1-) were multiplied
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to each of the β and k parameters respectively.
When a patient is on the antiretroviral cocktail therapy, the HIV viral load is
undetectable which could be ignored in the basic model. This assumption will allow
us to incorporate the dynamics of various T-cell subsets such as na¨ıve and memory
as shown in [24,26].
1.3.1 Stochastic Modeling
Despite the simplicity and elegance of the ODE models, we cannot ignore the
fact that the human cell dynamics are not deterministic and are subject to random
fluctuations due to natural variability. Hence various mathematical modelers have
switched gears and started using stochastic models to describe the HIV-immune
system dynamics. One of the earliest stochastic models was developed by Merill’s
et al, where he was able to model aspects of the immune system response in the
presence of HIV using a branching process [40]. In addition, Perelson et al [39] were
able to estimate the probability that one virus could infect on average one CD4
T-cell. However, there aren’t many studies that modeled the dynamics of na¨ıve and
memory CD4 T-cells subsets of chronically infected HIV patients. In this thesis,
we will be developing a stochastic model for the na¨ıve and memory CD4 T-cells
so we are able to observe the variability in this model that can be a result from
the natural variability, experimental error measurements and uncertainty in the
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parameter estimations of the T-cell dynamics.
1.4 Experiment
Highly active antiretroviral therapy (HAART), does a fairly good job in keeping
a low HIV viral load in the body of infected individuals. Despite the great effort
from scientists to help in restoring the immune system in HIV positive individuals,
patients remain to have a low count of T-cells in the body.
As we have seen in the previous section, CCR5 is a major co-receptor for the entry
of the HIV virus into the CD4 T-cells. Our Collaborator, (Sekaly et al., 2013) at
Case Western, have designed an experiment to study the effects of the introduction
of CCR5-down-modulated memory CD4 T-cells into HIV positive patients. The
main intention of this experiment is to examine if the perturbation of the system
will result in any augmentation in the CD4 memory T-cell count and the activity of
the immune system.
Information about the 3 cohorts
In this study 9 chronically infected HIV patients participated in this study. Where
all of these patients were receiving a HAART drug therapy. Table 1 summarize the
infection state, age , ethnicity and drug dose infused. The mean age of the patients
was 49 ± 6.49 years and the mean period of the infection diagnosis is 20.77 ± 6.47
years.
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Injection of CCR5-down-modulated memory CD4 T-cells and its quan-
tification.
As illustrated in Table 1.1, the nine HIV patients were separated into three groups
based on the injected dose of zinc finger nuclease (ZFN) driven CCR5-disrupted CD4
T-cells (SB-728-T). In order to measure the cells count for the 5 T-cell populations,
samples of Peripheral blood mononuclear cells (PBMCs) were collected from each
of the 9 patients at several time intervals. These PBMC were transduced by an
adenovirus encompassing a Zn Finger endonucleae that targets the CCR5 gene.
To identify each of the memory T-cell subsets, PBMCs were stained by different
cytometry panels(Sekaly et al., 2013). In this work, we defined the total CD4 T-cells
as the sum of the the five T-cell subsets unlike how it is quantified in the experiment.
The distribution of the injected CCR5-down-modulated memory CD4 T-cells is
illustrated in Figure 1.7 below.
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Figure 1.7: Ratio of infused CCR5-down-modulated- CD4 T-cell subsets.
In here the CD45RAlowROlow are considered as memory stem cells. These ratios
were adapted from the experimental study report by (Sekaly et al., 2013).
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ID Period of Inf.(years) Dose infused CD4 T-cell count at M0 CD4 T-cell count at M36
103 20 1x1010 188 -134.4 315-262.1
104 21 1x1010 261-205.4 455-378.7
102 25 1x1010 439-349 518-428.1
203 21 2x1010 294-227.7 617-4628
302 19 2x1010 413-279.6 606-468.7
201 30 2x1010 525-354 848-651.4
304 13 3x1010 306-215.6 757-444
303 28 3x1010 330-211.8 525-391.5
305 10 3x1010 480-347 340-271.8
Table 1.1: Information about the three cohorts.
This table illustrates the dose infused, infection period and the CD4 T-cell count at
baseline and after three years. The highlighted numbers are the T-cell count
defined by our collaborators Sekaly et al. and the non highlighted ones are simply
defined as the sum of the na¨ıve and memory CD4 T-cells, which is what is used
throughout this work.
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1.4.1 Data Description
The analysis in this thesis uses an unbalanced longitudinal data obtained from
the clinical described above. Longitudinal data is defined as observations usually
taken from several individuals at various time points. At time t=0, the CCR5-down-
modulated memory CD4 T-cells were injected into the three cohorts with different
dosages as illustrated in Table 1.1. After the injection, the nine patients were
followed over three years and measurements of the na¨ıve and memory CD4 T-cells
and their CCR5-down-modulated versions were taken at different time intervals for
each of the patients. Looking at the spaghetti plots in Figures 1.8 and 1.9, we can
make the following observations about the collected data :
• In total there are approximately 450 observations, where some of the missing
points could be due to patient inability to respect the follow up appointment,
or experimental error measurements.
• The down-modulated CCR5 CD4 T-cells have a very low count.
• The modified na¨ıve CD4 T-cell sub-population data is sparse.
• Memory stem cell populations measurement are missing as these were not
determined from the total T-cell count in the laboratory until much later in
the experiment.
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• The na¨ıve and central memory cell populations seem to increase in count in
most of the nine patients from its baseline value.
• The effector and transitional memory cells seem to increase or stabilize at a
value close to its baseline in most of the nine participants.
• The total number of the CD4 T-cell in here is not defined as the sum of all the
CD4 T-cell sub-populations due to the strict definition used in the experiment
protocol used in the laboratory.
When working with experimental data, it is important to draw some general obser-
vations before starting any analyses. These observations are usually important in
understanding what fitting routines are more suitable and why some would fail in
quantifying some parameters.
Figure 1.8 below presents the raw experimental data for each of the three cohorts:
Low (103, 104, 102), medium (203,201,302). Figure 1.9 illustrates the high dose co-
hort(304,305,303). In all of the three cohorts, the different cell counts are represented
by different colors where we have the the modified and its corresponding natural
cell subset on the same graph. The figure legend indicates each cell population and
the color where:
• N= na¨ıve cell
• MN= modified na¨ıve cell
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• ST = memory stem cell
• MST= Modified memory stem cell
• C= central memory cell
• MC= modified central memory cell
• T= Transitional memory cell
• MT= modified transitional memory cell
• E= effector memory cell
• ME= modified effectot memory cell
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Figure 1.8: Na¨ıve and Memory CD4 T-cell count for the low and medium dose
cohorts.
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Figure 1.9: Na¨ıve and Memory CD4 T-cell count for the high dose cohort.
1.5 Scope of Thesis
Several studies have shown that memory CD4 T-cells are a major contributor
to the control of the HIV infection in the host [24]. In (Ostrowski et al, 1999), it
was shown that na¨ıve and memory CD4 T-cells were infected by the HIV-1 virus in
vivo. Some researchers focused on studying the dynamics of the memory CD4 T-cell
population in HIV infected individuals [24,28]. Others have focused on studying
the importance of CD4 memory T-cells in the viral reservoir, as these memory cells
are latently infected which when activated can infect hundreds of cells. The role of
32
these cells in relation to the progression to the AIDS condition is studied as well
[26,36].
Since CCR5 is a primary co-receptor for the entry of the HIV virus into the host
cells, and since the memory CD4 T-cells are primary HIV reservoir in the host [58],
our work will evaluate the effect of introducing CCR5-down-modulated memory
CD4 T-cells into HIV positive individuals, on the CD4 T-cell dynamic. The goal of
this thesis is to determine what immune system na¨ıve or memory cells proliferation,
death, transition or birth rates are important in augmenting the memory T-cell
population, and if there exists a significant augmentation at all.
We will address this question by introducing deterministic, stochastic and statistical
models. My thesis is structured in following manner:
Chapter 2, I will present the deterministic and stochastic models used in this work.
The non-linear ordinary differential equation model was developed by considering a
linear transition model for the na¨ıve and memory CD4 T-cell as suggested by our
immunologist[52]. Later, a stochastic model is developed to account for the T-cell
natural variability using the Gillespie Algorithm.
Chapter 3, I will present the fitting results obtained using various fitting pro-
cedures. Fitting routines were carried in Monolix software, Matlab programming
language and and Stan. We will present baseline fit (using only data points at time
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0) and fits carried after the injection of the CCR5-down-modulated memory CD4
T-cells.
Chapter 4, using an uncertainty sensitivity analysis technique, we will use the
Latin Hypercubic sampling, coded in Matlab, to study the importance of each of
the 15 model parameters, on each of the 5 subsets of CD4 T-cells using the Partial
Rank Correlation Coefficients. This correlation is evaluated continuously after the
treatment initiation over 200 days. Studying this correlation is important in order
to understand what cell functions (death, proliferation or transition) and population
size was affected by the experimental treatment.
Chapter 5 will be devoted to present the results and discussion about the
stochastic model that we developed. Stochastic simulations are used to study
variability in the cell dynamics by estimating the variance in the 5 CD4 memory
T-cells populations. This will allow us to further determine whether the observed
increase in the memory T-cell population in the laboratory is not lost in the variance
of the cell dynamics from the model.
Lastly, in Chapter 6, I will present the conclusion obtained from this work where
we determine which of the memory CD4 T-cell population functions was important
in augmenting the CD4 T-cell count. As well, I will present some new directions for
future research in this area.
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2 The Model
2.1 Introduction
The goal of this thesis is to model a new HIV treatment, and determine whether
natural fluctuations in CD4 T-cell count can include observed increases in CD4
T-cell count in patients. Before we introduce any analysis, the first step needed is to
develop a mathematical model that describes the dynamics of the na¨ıve and memory
CD4 T-cells. In this chapter, first we will describe the deterministic model used in
this work. This model will be used in chapter 3 to estimate the model parameters
and in chapter 4 to perform an uncertainty and sensitivity analysis to study the
relative significance of each of the model parameters with respect to each of the
na¨ıve and memory CD4 T-cell subsets. Second, a stochastic model is derived based
on the Gillespie Algorithm, which will be used in chapter 5 to study variability in
the na¨ıve and memory CD4 T-cell populations. This is important to understand
the occurrence of random variation in the CD4 T-cell count in the body.
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2.2 Na¨ıve and Memory CD4 T-cell Dynamical Model
In order to perform our parameter estimation, first we need to specify a mathe-
matical model that describes the dynamics of the na¨ıve and memory CD4 T-cell
subsets. Our collaborators in Case Western University [52], proposed that memory
CD4 T-cell subsets have a linear transition. Using this assumption, we constructed
a system of ODE’s to describe the transition process from the na¨ıve to the effector
memory state. The na¨ıve and memory CD4 T-cell population is divided into 5
subsets, na¨ıve (N), stem (ST), central (C), transitional (T), and effector (E), where
each of these populations have death, proliferation and transition rates. In addition,
the na¨ıve cells have a birth rate as these cells are produced by the thymus. The
effector memory cells do not transition to any other subset, as this is a terminal
state. The following are some model assumptions made for the natural and CCR5
down-modulated memory CD4 T-cells.
• No backward transitions occur between the na¨ıve an memory CD4 T-cell
subsets.
• The CCR5-down-modulated memory CD4 T-cells follow the same dynamics
presented for the natural CD4 T-cells.
• There is no interaction between the natural and injected modified memory
CD4 T-cells.
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• For model simplicity, and since the injected modified memory CD4 T-cells
have a very small population size, we will assume that they have the same
proliferation, death and transition rates as the natural ones.
• The modified na¨ıve T-cells will not have a birth rate as these cells could not
be produced naturally by the thymus.
• We assume that the blood is a well mixed homogeneous environment.
Figures 2.1 and 2.2 illustrate a flow diagram that describes the dynamics of the
natural and CCR5-down-modulated memory CD4 T-cells respectively.
Parameters and variables used in both system of ODEs (Eq’s 2.1 and 2.2) and the
flow diagrams are described in Table 2.1 and 2.2 below.
Both natural and modified CD4 T-cells follow a linear transition from the na¨ıve
to the effector terminal state. The model is described as follows:
• The thymus is producing λ natural na¨ıve cells per day.
• The na¨ıve cells have a death rate dN , a proliferation rate pN , and transition
to become memory stem cells with a rate φN .
• Memory stem cells have a death rate dST , a proliferation rate pST and transition
to become a central memory cell with a rate φST .
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Variables Definition
N CD4 na¨ıve T-cell
ST CD4 memory stem T-cell
C CD4 central memory T-cell
T CD4 transitional memory T-cell
E CD4 effector memory T-cell
MN Down-modulated CCR5 CD4 na¨ıve T-cell
MST Down-modulated CCR5 CD4 memory stem T-cell
MC Down-modulated CCR5 CD4 central memory T-cell
MT Down-modulated CCR5CD4 transitional memory T-cell
ME Down-modulated CCR5 CD4 effector memory T-cell
Table 2.1: Variables used in systems of ODEs 2.1 and 2.2.
38
Param. Definition and units
λ Number of na¨ıve cells produced by the thymus per day
pN proliferation rate of natural and down-modulated na¨ıve CD4 T-cells per day
−1
φN Transition rate of natural and down-modulated na¨ıve CD4 T-cells per day
−1
dN Death rate of natural and down-modulated na¨ıve CD4 T-cells per day
−1
pST Proliferation rate of natural and down-modulated stem memory CD4 T-cells per day
−1
φST Transition rate of natural and down-modulated stem memory CD4 T-cells per day
−1
dST Death rate of natural and down-modulated stem memory CD4 T-cells per day
−1
pC Proliferation rate of natural and down-modulated central memory CD4 T-cells per day
−1
φC Transition rate of natural and down-modulated central memory CD4 T-cells per day
−1
dC Death rate of natural and down-modulated central memory CD4 T-cells per day
−1
pT Proliferation rate of natural and down-modulated transitional memory CD4 T-cells per day
−1
φT Transition rate of natural and down-modulated transitional memory CD4 T-cells per day
−1
dT Death rate of natural and down-modulated transitional memory CD4 T-cells per day
−1
pE Proliferation rate of natural and down-modulated effector memory CD4 T-cells per day
−1
dE Death rate of natural and down-modulated effector memory CD4 T-cells per day
−1
pterm Limiting factor for the proliferation rate
Table 2.2: Variables used in the systems of ODEs 2.1 and 2.2.
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Figure 2.1: Flow Diagram presenting the dynamics of the na¨ıve and memory CD4
T-cell
Figure 2.2: Flow Diagram presenting the dynamics of the down-modulated CCR5
na¨ıve and memory CD4 T-cell
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• Central memory cells have a death rate dC , a proliferation rate pC and
transition to become a transitional memory cell with a rate φC .
• Transitional memory cells have a death rate dT , a proliferation rate pT and
transition to become an effector memory cell with a rate φT .
• Effector memory cells have a death rate dE, a proliferation rate pE. This is a
terminal state.
Modified CD4 T-cell follow the same dynamic described above but na¨ıve cells are
not produced by the thymus, so we do not have the λ term as shown in Figure 2.2.
The system of ODEs, Eq’s 2.1 and 2.2, represent the dynamics of the natural
na¨ıve and memory CCR5 CD4 T-cell and down modulated CCR5 memory CD4
T-cell populations. The pterm in these equations represents a limiting factor as the
T-cells cannot proliferate infinitely. At maximum there is a 1000 T-cells in 1 µL of
plasma in the body of any healthy individual. So the proliferation rate of the CD4
T-cells is described by a logistic growth[54], So any subset of the CD4 T-cell can
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only generate with a chance 1-N+MN+ST+MST+C+MC+T+MT+E+ME
1000
N ′ = λ− dNN − φNN + pNptermN
ST ′ = φNN − dSTST − φSTST + pSTptermST
C ′ = φSTST − dCC − φCC + pCptermC
T ′ = φCC − dTT − φTT + pTptermT
E ′ = φTT − dEE + pEptermE (2.1)
MN ′ = −dNMN − φNMN + pNptermMN
MST ′ = φNMN − dSTMST − φSTMST + pSTptermMST
MC ′ = φSTMST − dCMC − φCMC + pCptermC
MT ′ = φCMC − dTMT − φTT + pTptermMT (2.2)
ME ′ = φTMT − dEME + pEptermME
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2.3 Stochastic Model
2.3.1 Introduction
As mentioned in chapter 1, in mathematical modeling there exist two types
of models that are widely used to study the dynamics of infectious disease at the
cellular and molecular scales; deterministic and stochastic models. Despite the
advantages of using deterministic models to describe biological phenomenons, in
a realistic world we know that human cells thrive in a Brownian world. The cell
motion in the body can be described as partly discreet and partly random. Hence,
the appropriate mathematical tools describing such motion are stochastic models
that can capture variability in the Brownian world [49].
2.3.2 Continuous Time Markov Chain Model
Using the deterministic model presented by Eq’s. 2.1 and 2.2, we develop a
stochastic model. Here, time, represented as t, is considered to be continuous where
t ∈ [1,∞) and variables are discrete.
Let N(t), ST(t), C(t), T(t), E(t) be random variables representing the number
of na¨ıve, stem, central, transitional, and effector memory CD4 T-cells at time t,
respectively. These random variables are defined to be discrete and non-negative.
And, let the transition probabilities that represent the change in state of the 5 CD4
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T cells subsets be:
prob∆N(t) = i,∆ST (t) = k,∆C(t) = w,∆T (t) = v,∆E(t) = l (2.3)
Here we assume that the time step ∆t is sufficiently small that only one event can
occur at time t [49] i.e. each of the variables i, k, w,v and l can take only three
values +1, -1 , 0 to describe what event is taking place during the time interval ∆t.
Table 2.3 lists all the fifteen possible outcomes that could occur in one time step
∆t, their transition events and their corresponding transition probabilities. Note
that this stochastic model is based on Eq’s 2.1, as the modified memory CD4 T-cell
population size is very small and is not the main focus in this work.
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Reaction Events Transition Rate at Which
Each Event Occur
Transition Prob-
ability In Time
Interval [t,t+∆t]
1 Birth of na¨ıve Cells N → N+1 λ λ ∆t
2 Death of N N → N-1 dN dN ∆t
3 N proliferation N → N+1 pN pterm pN pterm ∆t
4 Transition from N to STM N → N-1 and
STM → STM+1
φN φN ∆t
5 death of STM STM → STM-1 dST dST ∆t
6 proliferation of STM STM → STM+1 pSTpterm pSTpterm
7 transition of STM to CM STM→STM-1,
CM→CM+1
φST φST ∆t
8 death of CM CM →CM-1 dCM dCM ∆ t
9 CM proliferation CM →CM+1 pCMpterm pCMpterm ∆t
10 Transition from CM to TM CM→CM-1,
TM→TM+1
φCM φCM ∆t
11 Death of TM TM → TM-1 dTM dTM ∆t
12 Proliferation of TM TM → TM+1 pTMpterm cell3
13 Transition from TM to EM TM→TM-1,
EM→EM+1
φTM φTM ∆t
14 Death of EM EM → EM-1 dEM dEM ∆t
15 Proliferation of EM EM → EM+1 PEMpterm PEMpterm ∆t
Table 2.3: Transition Events and their corresponding probabilities for the fifteen
possible outcomes for the 5 CD4 T-cell subsets.
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The transition probabilities of the fifteen possible different state for the five
cell populations are presented below, where high order term are assumed to be 0 (
lim∆t→0
o(∆t)
∆t
=0). Equation 2.4 below, describes the Markov jump process, where
each event takes place at a particular rate given the current state of the system.
prob∆N(t) = i,∆ST (t) = k,∆C(t) = w,∆T (t) = v,∆E(t) = l| (2.4)
N(t), ST (t), C(t), T (t), E(t) =
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
λ∆t+ o(∆t), (i, k, w, v, l) = (1, 0, 0, 0, 0)
dN∆t+ o(∆t), (i, k, w, v, l) = (−1, 0, 0, 0, 0)
pNpterm∆t+ o(∆t), (i, k, w, v, l) = (1, 0, 0, 0, 0)
φN∆t+ o(∆t), (i, k, w, v, l) = (−1, 1, 0, 0, 0)
dST∆t+ o(∆t), (i, k, w, v, l) = (0,−1, 0, 0, 0)
pSTpterm∆t+ o(∆t), (i, k, w, v, l) = (0, 1, 0, 0, 0)
φST∆t+ o(∆t), (i, k, w, v, l) = (0,−1, 1, 0, 0)
dC∆t+ o(∆t), (i, k, w, v, l) = (0, 0,−1, 0, 0)
pCpterm∆t+ o(∆t), (i, k, w, v, l) = (0, 0, 1, 0, 0)
φC∆t+ o(∆t), (i, k, w, v, l) = (0, 0,−1, 1, 0)
dT∆t+ o(∆t), (i, k, w, v, l) = (0, 0, 0,−1, 0)
pTpterm∆t+ o(∆t), (i, k, w, v, l) = (0, 0, 0, 1, 0)
φT∆t+ o(∆t), (i, k, w, v, l) = (0, 0, 0,−1, 1)
dE∆t+ o(∆t), (i, k, w, v, l) = (0, 0, 0, 0,−1)
pEpterm∆t+ o(∆t), (i, k, w, v, l) = (0, 0, 0, 0, 1)
1− (λ+ (dN + pNpterm+ φN)N(t) + (dST + pSTpterm+ φST )ST (t)+
(dC + pCpterm+ φC)C(t) + (dT + pTpterm+ φT )T (t) + (dE + pEpterm)E(t)),
(i, k, w, v, l) = (0, 0, 0, 0, 0)
o(∆t), Otherwise.
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2.3.3 Implementation of the MCMC simulations using the Gillespie’s
Algorithm
We implemented the stochastic simulations framework in matlab using the
Gillespie’s Direct algorithm [55].
In this method two uniformly distributed random variables defined in the interval
(0,1) are used in each iteration. The first random variable is used to simulate
the time step and the second is to select the event. Below is a description of the
Algorithm used.
• Label all possible events of birth, proliferation, death and transition for all
the five cell populations as E1, ...., En.
• Define the rate at which event occurs as R1 ... Rn.
• Generate two uniformly distributed random variables: RAND1 and RAND2
• the rate at which any event could occur is expressed as:
Rtotal =
n∑
i=1
Ri
• The time step between events is :
∆t= −log(RAND1)
Rtotal
• Set P = RAND2Rtot
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• Event P occurs if
p−1∑
i=1
Ri < P <
p−1∑
i=1
Ri
• Time t is now update as t t+ δt and the event P occurred.
• Return to step 2
In this algorithm, the transition rates are converted into probabilities where one
random event is selected at each time step. Once selected, the time step and the
number in each of the events is updated accordingly following the algorithm above
[49].
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3 Data Fitting Results
3.1 Introduction
The most important step in this work is the parameter estimation task. Using
the non-linear ODE model described by Eq’s 2.1 and 2.2, we will explore several
fitting routines using different software to estimate the model parameters. This
chapter is organized as follows:
• In section 3.2, we will introduce the use of the non linear mixed effect models
in fitting dynamical biological data using several software.
• In section 3.3, we will present the baseline fit obtained using Matlab, where
only data measurement at time 0 (before the infusion of the modified CD4
T-cells)is used.
• In section 3.4, we will present the data fitting obtained using Stan software
where a hierarchical technique is used to fit all the data measurements obtained
after the dose for the ten populations of cells.
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• In section 3.5, Monolix fitting results is presented, where a non linear mixed
effect approach is used. Model diagnostics for the three cohorts are achieved
using several statistical tests and outputs to compare the different fits obtained
in Monolix. Here data measurements after the dose are used.
• In the last section 3.6, parameter identifiablity and over fitting issues that
occurred in the fits are discussed.
3.2 Non Linear Mixed-effects models and software
We proposed a system of ODEs for this study. However, many of the ODE
parameters are unknown. Several statistical methods have been developed to
estimate model parameters from experimental data such as Bayesian estimation
and non linear mixed effect models [42]. Using non-linear ODE models made the
fitting task harder as many of them do not have an analytic solution [42].
Bayesian hierarchical framework estimation uses a prior distribution obtained from
the subject’s data to estimate the individual parameters. This method is able to
capture the within and between individual’s variability [43,42].
Non-linear mixed effect model(NLME) uses a hierarchical framework which take into
account the inner and intra individual variability. This method allow to perform
statistical analysis on unbalanced longitudinal data. It is widely used to fit clinical
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trials data in sociology, biology, psychology and many more [43]. Mixed effect
models were originally introduced in the pharmacokinetics studies [43]. For more
information the reader could refer to Phinero and Bates (2000).
Many software packages have been developed in the area of fitting experimental
data to biological models. In this section we will introduce some software such as
NONMEM, STAN, Monolix and Matlab.
• NONMEM developed by S.L. Beal and L.B Sheiner in 1980 is a very famous and
widely used statistical software package in the pharmacokinetics community.
It performs a population parameter estimation where the maximum likelihood
is estimated using several approximation techniques such as the Laplacian
and first order methods [45]. This software has various advantages. One of
the most important advantage, is the ability to use compartmental and ODE
based models, where several dosing methods could be considered. However,
this software has several pitfalls. For instance, the graphical are sub-optional
and the user needs to pair it with other software such as R and excel to output
some graphics. In addition, fits are sensitive to the initial prior guess [46]. For
further reference the reader could refer to Bates (2000).
• Stan is a statistical software package that estimates parameters using a
Bayesian approach. The user will have to write a Stan program in order
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to estimate the posterior distribution of the parameters as an initial estimates.
A hierarchical framework could be adopted in this case. Like any statistical
software, Stan has some limitations. For instance, the convergence time might
be very long. In addition, Stan does not allow the user to make inferences
about discrete parameters such as the case in mixture models [44].
• Monolix is a new statistical software package developed by Marc Lavielle and
implemented in Matlab, that models non linear mixed effect models [51]. It is
based on the Stochastic Approximation of the Expectation-Maximization,SEAM,
using a Monte Carlo Markov Chain (MCMC)iterative algorithm. This algo-
rithm is used to estimate the maximum likelihood estimator of the model
population parameters, where a simulated annealing version improves the
convergence of the model to a global maximum. The MCMC iterative method
uses the Metropolis- Hastings approach. One of the drawbacks of this software
package is its sensitivity to the initial guess provided when performing the fit
[50,51].
A more detailed explanation of the algorithm is presented in Appendix A.
• Matlab is a very famous mathematical software package that has a statistical
toolbox that consists of many statistical packages. Depending on the kind
of data, one may choose some linear and non linear least square methods
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functions such as lsqln, lsqnonlin and fminsearch. These functions works by
minimizing the distance between the ODE curve and the observations. The
second fitting option available in Matlab is to use a non linear mixed effect
method functions such as nlmefit and nlmefista. nlmefit uses the Likelehood
Maximization Expectation (LME) or Laplacian first order to estimate the
parameters. However, nlmefista use the SEAM algorithm to approximate the
model parameters [47].
Parameter estimations in this thesis are carried out using three different fitting
software; Monolix version 4.4, Matlab and Stan. In the next sections, we will
present the fitting results obtained from these three software. Model diagnostics and
goodness of fit were studied using the Akiake Information criterion (AIC), standard
error values (s.e) and other figure output such as individual fits and prediction vs
observations graphs.
3.3 Data Fitting
We first determine model parameter values at baseline, and then fit the model
to the data after the dose. This methodology will us to determine which parameters
are most affected by the dose of CCR5 down-modulated cells.
54
3.3.1 Baseline Fit- Matlab
In order to better understand the effect of the injected CCR5-down-modulated
memory CD4 T-cell in each of the nine patients, we first performed a baseline fit
in Matlab using a hierarchical mixed model using a log-norm distribution for the
parameter’s mean. This approach allows one to fit all the nine patients to their
baseline count (data point at time 0) while allowing for inter patient variability.
We used a non-linear least square data fitting method. Table 3.1 summarizes the
results obtained for all the patients where we grouped them by the dose of injected
CCR5-down-modulated memory CD4 T-cells (high(yellow), medium (white), low
(gray)). The standard deviation and mean for the parameters is illustrated.
Pat λ dN dST dC dT dE φN φST φC φT pN pST pC pT pE
303 8.4457 .0096 0.0112 0.0033 0.0231 0.5151 0.0823 0.4648 0.1079 0.2479 0.0011 0.0110 0.0109 0.0215 0.0332
304 9.0864 0.0102 0.0110 0.0033 0.0231 0.3887 0.1709 0.4648 0.1075 0.2426 0.0011 0.0110 0.0109 0.0216 0.0332
305 10.5165 0.0114 0.0110 0.0033 0.0230 0.3215 0.0693 0.4648 0.1059 0.2333 0.0011 0.0110 0.0109 0.02179 0.0332
201 10.9220 0.0118 0.0110 0.0033 0.0232 0.4467 0.0746 0.4648 0.1022 0.2444 0.0011 0.0110 0.0110 0.0216 0.03320
203 9.1081 0.0102 0.0111 0.0033 0.0234 0.3750 0.1644 0.4648 0.1055 0.2493 0.0011 0.0110 0.01089 0.0215 0.0332
302 8.7649 0.0100 0.0111 0.0033 0.0232 0.2889 0.0497 0.4651 0.1107 0.2477 0.0011 0.0109 0.0108 0.0216 0.0332
102 9.1713 0.0104 0.0111 0.0033 0.0234 0.0909 0.2153 0.4636 0.1053 0.2478 0.00115 0.0110 0.0109 0.0216 0.0335
103 6.1309 0.0073 0.0111 0.0033 0.0232 0.4530 0.1558 0.4643 0.1071 0.2452 0.0011 0.0110 0.0109 0.0215 0.0331
104 7.6965 0.0089 0.0111 0.0033 0.0232 0.1297 0.2673 0.4673 0.1085 0.2495 0.0011 0.0109 0.01090 0.0216 0.0336
mean 8.9189 0.0100 0.0111 0.0033 0.0231 0.3388 0.1391 0.4648 0.1069 0.2453 0.0011 0.0110 0.0109 0.0216 0.0332
std 1.3756 0.00126 0.00085 0.00029 0.0017 0.1364 0.0702 0.0121 0.00405 0.0117 8.6456e-05 0.00074 0.00071 0.0015 0.0024
Table 3.1: Baseline fit for the three cohorts obtained using Matlab.
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3.3.2 STAN Fitting results
Dr. Georges Monette performed a parameter estimation in Stan. In the fit,
he used a hierarchical approach where all the patients are fit using an iterative
MCMC approach model using sampling and population variance. A more detailed
explanation about this fit is presented in Appendix B.
Table 3.2 shows the fit obtained for the nine patients.
Pat λ dN dST dC dT dE φN φST φC φT pN pST pC pT pE
303 10.2921 0.00936 0.0006 0.0804 0.0431 0.1 0.0986 0.1419 0.0196 0.0575 0.0078 0.0425 0 0.0007 0
304 8.3817 0.0092 0.0004 0.0467 0.0534 0.1 0.135 0.2234 0.0533 0.0466 0.00277 0.1237 0 0 0
305 11.2318 0.0511 0.0002 0.0658 0.0073 0.1 0.0492 0.2358 0.0342 0.1082 0.0003 0.1360 0 0.0155 0
201 19.3183 0 0.0058 0.0724 0.0571 0.1 0.1576 0.0984 0.0276 0.0429 0.05761 0.0042 0 0 0
203 6.9429 0.0080 0 0.0775 0.0249 0.1 0.1014 0.2243 0.02255 0.0780 0.0094 0.01243 0 0.0030 0
302 16.1964 0.0483 0.0083 0.0686 0.0015 0.1 0.0517 0.1024 0.0314 0.1341 0 0.0107 0 0.0356 0
102 7.4924 0.0028 0 0.07919 0 0.1 0.1171 02375 0.0281 0.188 0.02 0.1375 0 0.0880 0
103 2.7117 0.0136 0 0.0627 0 0.1 0.0973 0.3590 0.0373 0.1886 00109 0.2590 0 0.0887 0
104 6.47731 0.0012 0.0054 0.0744 0.0007 0.1 0.1401 0.1158 0.0256 0.1584 0.0413 0.0213 0 0.0590 0
Table 3.2: Hierarchical Fit obtained from Stan software. 2000 iterations are used.
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3.3.3 Monolix Fitting Results
A non-linear mixed effect approach was employed to estimate the model param-
eters. Using Monolix software, we have used 3 fitting approaches. In the first two
approaches, we used the data points provided for all ten cell populations. In the
third approach, we used the data points for the non-modified na¨ıve and memory
CD4 T-cell only. The two main reasons behind ignoring the down-modulated CCR5
memory CD4 T-cell populations, is because of its small size and its short lifespan in
the body, which varies between three to five years on average [56].
When performing the fit, Monolix requires the user to specify an initial guess for
the fixed effect parameters. One of the good advantages this software provides, the
ability to check the initial fixed effect. First, we have started with the baseline
fit presented in Table 3.1 as an initial guess. Using the initial fixed effect tool,
the model parameters were altered sometimes where we minimized the distance
between the curve and the experimental data points by seeing the change of the
curve instantly to get a good initial guess [50,51].
• In the First approach, we used a stochastic approximation of the Fisher
Information Matrix. In here the Fisher Information Matrix is calculated using
the exact model. The experimental data measurements provided for all the
ten cell populations is used. Eq’s 2.1 and 2.2 are used. This fitting routine
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will be referred to as SNM throughout this work.
• In the second approach, we used a model linearization approach to estimate the
Fisher Information Matrix where the model is linearized and is approximated
by a Gaussian model. As well, the data points for all 10 cell populations is
used. So we have used Eq’s 2.1 and 2.2. This fitting routine will be denoted
as LNM throughout this work.
• In the third approach, we have only used the data points of the non-modified
na¨ıve and memory CD4 T-cell. Eq’s 2.1 are used. For this approach we used
a model linearization to calculate the Fisher Information Matrix. This fitting
routine will be referred to as LN throughout this work.
3.3.3.1 A non-linear mixed effect model for the T-cell dynamical model
As described earlier, our dynamical model consists of ten populations of na¨ıve
and memory CD4 T-cells for each of the nine patients. We present the concentration
for each of the compartment at time, t. This work considers time to be the only
dynamic variable in the model. In this fitting routine, we have used the same
individual based model for the observations from the nine patients independently.
The vector of observation at time tj is presented as yj where 1 < j < n. The model
is the distribution of the vector of observation yi represented as py(.;φ, t).
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A non-linear model is composed of fixed effect, random effect , residual error model
and a covariate model can be added if needed. Where the fixed effect and random
effect account for variability between and within individuals respectively. In this
study, age, sex and ethnicity were not taken into account, hence there was no need to
specify a covariate model. Having said that, we will have a 15 by 15 zero covariance
model, as we have 15 unknown parameters to be estimated.
Due to a limitation in the Monolix software package where different initial conditions
for each of the cell populations for each of the nine patients was not possible. Since
patients are independent and share no information, we decided to consider an
individual- based model where we fit the cell populations to patient separately.
This is a drawback, since they will be related through distribution showing the
inter-patient variation related over these parameter distributions. The Non-linear
mixed effect model which represents our set of ODE equations is represented as:
Yijl = xil(tij) + eij (3.1)
Where we have the following:
• i = 1....N = the ith individual.
• j = 1...ni = the time point.
• l= 5 or 10, which is the l’th number of compartment in the ODE model.
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• β= the fixed effect, b = the random effect and eij= residual error model.
As many non-linear ODEs do not have an analytic solution, Monolix uses a
numerical approximation technique to solve the ODEs. A non linear optimizing
method is commonly adopted to fit these types of ODE’s to experimental data. The
user has to determine the initial conditions for each of the cell populations or else
they are considered to be zero by the software. Hence, baseline measurements for
each of the cell population are used as initial conditions.
In order to perform a fit in Monolix, the user has to determine the distribution
for the parameters. Defined by the user, Monolix compares different paramater
distributions and chooses the best model based on the Akiake Information Criterion
(AIC), Bayesian Information Criterion (BIC) and -2 of the likelihoods (-2LL). For
our model, it was shown that the a log-normal distribution resulted with the smaller
AIC, BIC and -2LL values, where log(φi) = log(θ) + ηi. log(θ) represents the mean
value of the fixed effect parameters and ηi is the random effect to account for
inter-individual variability.
When performing data fitting, one cannot ignore the error that occurs when mea-
suring experimental data. Hence it is important that for any given data set, we
determine an error model that potentially estimates the distribution of the error in
the data measurements. The residual error model defines the conditional probability
distribution of the observations denoted by yij. Using the Akiake and Bayesian
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Information Criterion (AIC and BIC) and the Likelihood (-2LL ), Monolix proposed
that a constant error model best describes our model and data data, where eij = diij
and ij is normally distributed ∼N(0,d2).
3.3.3.2 Akiake Information Criterion
To evaluate the difference between the three fitting techniques, I have used
the Akiake Information Criterion (AIC) and the standard errors to compare the
goodness of fit.
The AIC takes into account the number of parameters, data points and the likelihood,
with K and N being the number of parameters and data points respectively and is
defined by the equation below [50]:
AIC = −2loglm(y; θ) + 2K + ((2K(K + 1))/(N −K − 1)) (3.2)
In this section, the number of parameters(K=15), was the same for all the three
fits. What changed is the number of observations and cell populations used in the
model. Hence, having a smaller AIC indicates the most parsimonious model. In
addition, to asses the best and most efficient model, the central processing unit time
(CPU) and the standard error are used to asses the efficacy of the model [48]. The
standard error is calculated by taking the ratio between the standard deviation of
the estimated parameter and the estimated value for the parameter [48]. Besides
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the above statistical tests, we have used the plot for the individual fits to asses the
goodness of fit. Moreover, the observed vs prediction plots were used, where when
the data points are more aligned to the 45o degree line it indicates a better fit.
3.3.3.3 Parameter Estimation Results
In the subsections below, we will compare the three fitting routines for the three
cohorts. A table showing the three different fits along with the standard error, AIC
and CPU time are shown. In addition, I will present some of the plots obtained
by Monolix such as the individual fits and the observed vs’ predictions outputs to
get a better insight about the quality of the fits. The ODE model described by
Eq’s 2.1 and 2.2 were solved over 1080 days in all the fits. In the case where we
considered to fit the modified and non-modified memory and na¨ıve CD4 T-cells,
we have indicated that the modified-cell dose was injected into the patients after
the measurement of their cell count at baseline at time 0. In all of the subsections
below, results for non- modified CD4 na¨ıve and memory T-cell populations will be
presented, as these cell populations are the main interest of this work.
Patient 103- Low Dose
Table 3.3 below shows the parameter estimates for patient 103. When all the
experimental data points for the ten cell populations of cell were used, adopting a
stochastic approximation or model linearization to calculate the Fisher Information
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matrix, we obtained the same values. However, using the model linearization
approach, the software was able to calculate the s.e with the smaller CPU time.
When comparing both the s.e values and the AIC, we can see that the fitting routine
where only non-modified cell data points were used, resulted a better fit giving an
AIC of 262, almost half that of the other models. Parameter values from all fitting
exercises are somewhat similar in magnitude. A NaN value of the s.e means that
either the coefficient is 0 or the software was not able to capture the parameter.
Comparing the CPU time from all three fits, it is evident that when only the
non-modified cell data is used, the fitting exercise is less computationally expensive.
Looking at Figures 3.1, we can see that the model was not well fitted to the data as
most of the observations were not close to the 45opurple line. This further indicates
that the model prediction is not perfectly close to the experimental data points.
From Figure 3.2, we can make the following observation about the change in the
memory and na¨ıve CD4 T-cell populations from the best fit model:
• The na¨ıve cell population decreased.
• The memory stem cell population had a very small increase.
• The central, transitional and effector memory cell populations have increased.
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Param Lin-all s.e Stoch-all s.e Lin-non s.e
λ 5.83 9.5e+005 5.83 3.2 6.14 2.4e+007
pN 0.000855 1.6e+005 0.000855 NaN 0.000201 NaN
pST 0.0064 NaN 0.0064 NaN 0.0064 NaN
pC 0.09 5.7e+004 0.09 NaN 0.0821 1.6e+005
pT 0.0976 5.6e+005 0.0976 NaN 0.0639 6.8e+005
pE 0.483 8.2e+004 0.483 NaN 0.413 3.7e+006
φN 0.208 2.5e+004 0.208 0.066 0.217 2.7e+003
φST 0.426 1.1e+004 0.426 NaN 0.461 5.8e+003
φC 0.104 2.3e+003 0.104 0.031 0.117 4.2e+003
φT 0.319 1.7e+004 0.319 0.092 0.34 5.1e+005
dN 0.00565 4.9e+004 0.00565 0.084 0.006088 8.5e+005
dST 0.0105 5.6e+004 0.0105 NaN 0.00685 NaN
dC 0.00249 3.2e+004 0.00249 0.025 0.00564 1.2e+005
dT 0.0235 3e+005 0.0235 NaN 0.0327 NaN
dE 0.437 5.3e+004 0.437 0.065 0.498 2.5e+006
AIC 479.55 479.55 262.33
CPU (sec) 1.58e+003 7.37e+003 939
Table 3.3: This table illustrates the fits obtained from the three fitting approaches
with their AIC and standard error measurements for patient 103 .
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Figure 3.1: Pat 103 Prediction vs Observation.
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Figure 3.2: Individual fits of the na¨ıve and memory CD4 T-cells for patient 103.
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Patient 102-Low Dose
Table 3.4 shows the parameter estimates for patient 102. Similar to the previous
patient, when all experimental data points for the ten cell populations are used, the
stochastic approximation and the model linearization routines used to calculate the
Fisher Information matrix resulted in similar parameter estimates. However, using
the model linearization approach, the standard error was calculated in a shorter
CPU time. Comparing both the s.e values and the AIC, we can see that the fitting
routine where only non-modified cell data points were used gave a better fit where
we had an AIC of 261. Parameter values from both fits are somewhat similar in
magnitude except for the number of na¨ıve cells produced by the thy thymus daily;
λ. Looking at Figure 3.3, we can see that the model was not well fitted to the data
as most of the experimental data points did not lie on the 45opurple line, which
indicates that the model did not succeed in replicating the clinical trial. However,
the memory effector cell population seems to have a reasonable fit where the data
measurement lie on the 45o degree line.
From Figure 3.4, we can make the following observation about the change in the
memory and na¨ıve CD4 T-cell populations:
• The na¨ıve, memory stem cell, central and transitional cell populations have
increased from the baseline.
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• The effector memory cells have decreased in count.
Param Lin-all s.e Stoch-all s.e Lin-non s.e
λ 18.2 3.8e+006 18.2 14 13 1.9e+007
pN 0.0895 1e+006 0.0895 NaN 0.0871 4.4e+005
pST 0.159 1.3e+004 0.159 NaN 0.1 6.8e+005
pC 0.0511 8e+005 0.0511 NaN 0.0318 2.9e+005
pT 0.000167 NaN 0.000167 NaN 0.00181 NaN
pE 0.268 3.7e+003 0.268 NaN 0.19 1.7e+006
φN 0.227 1.6e+003 0.227 0.18 0.19 1.7e+006
φST 0.238 5e+004 0.238 0.2 0.235 3.7e+005
φC 0.0846 2.4e+005 0.0846 0.064 0.0963 3.4e+004
φT 0.319 1.7e+004 0.291 NaN 0.37 3.2e+005
dN 0.00489 NaN 0.00489 NaN 0.00715 NaN
dST 0.00196 5.1e+004 0.00196 NaN 0.00836 NaN
dC 0.00414 NaN 0.00414 2.5e+005 0.00474 NaN
dT 0.0408 9.9e+005 0.0408 0.23 0.0209 4.4e+005
dE 0.192 5.3e+004 0.192 0.032 0.316 9.6e+005
AIC 520.89 520.89 261.16
CPU(sec) 2.71e+003 2.76e+004 3.45e+003
Table 3.4: This table illustrates the fits obtained from the three fitting approaches
with the AIC and standard error measurement values for patient 102.
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Figure 3.3: Observed vs prediction output for patient 102.
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Figure 3.4: Individual fits for the na¨ıve and memory CD4 T-cells for patient 102.
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Patient 104 - Low Dose
Table 3.5 below shows the parameter estimates for patient 104. Again, when all the
10 cell populations data points are used, the stochastic approximation and model
linearization approaches to calculate the Fisher Information matrix, result in similar
parameter estimates. However, using the model linearization approach, the software
was able to calculate the standard error. The fitting routine considering only non-
modified cell population data gave a better fit, with an AIC of 210. Parameter values
from all fits are similar in magnitude. Based on the CPU time, AIC and standard
error values, the fitting routine considering only non-modified cell observations
resulted in a better fit. Looking at Figure 3.5 , we can see that the model was not
well fitted to the data for the na¨ıve, central memory and transitional memory cells.
However, observations for the stem and effector cells were well lined up with the
45o degree purple line in both the fits. The results from the individual fits in Figure
3.6 shows a good fit for the central, effector and memory stem cell populations.
From Figure 3.6, we can make the following observation about the change in the
memory and na¨ıve CD4 T-cell populations:
• The na¨ıve, central and memory stem cells have increased in count from the
baseline.
• The effector and transitional memory cells have decreased in count from the
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baseline.
Param Lin-all s.e Stoch-all s.e Lin-non s.e
λ 9.44 2.4e+007 9.44 9.5 8.73 2.6e+005
pN 0.000226 7.2e+002 0.000226 NaN 1.97e-005 65
pST 0.00417 2.3e+003 0.00551 NaN 0.00551 6.3e+003
pC 0.00365 1.9e+0053 0.0511 NaN 0.00365 NaN
pT 0.00335 2.1e+004 0.00335 NaN 0.00181 NaN
pE 0.00486 4.8e+003 0.00486 NaN 0.0139 6.9e+003
φN 0.135 3.7e+003 0.135 0.13 0.125 2.9e+003
φST 0.0759 .8e+003 0.0759 0.048 0.0679 8.8e+002
φC 0.0827 4.2e+003 0.0827 0.095 0.0715 2.4e+003
φT 0.368 5.9e+0034 0.368 0.47 0.32 8.6e+003
dN 0.0034 3.5e+005 0.0034 0.024 0.00261 1.1e+003
dST 0.0054 5e+003 0.0054 0.034 0.00836 NaN
dC 0.0827 4.2e+003 0.00435 0.056 0.0715 2.4e+003
dT 0.0187 3.8e+003 0.0188 NaN 0.0188 1.3e+004
dE 0.527 9.4e+003 0.527 0.68 0.475 1.2e+004
AIC 383.08 385.08 210.41
CPU (sec) 4.27e+003 1.78e+004 1.47e+003
Table 3.5: This table illustrates the fits obtained from the three fitting approaches
with their AIC and standard error measurements for patient 104.
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Figure 3.5: Observed vs prediction output for patient 104.
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Figure 3.6: Individual fits for the na¨ıve and memory CD4 T-cells for patient 104.
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Patient 203- Medium Dose
Looking at Table 3.6, we can observe that when using all the 10 population of
cells, Both the stochastic and model linearization approaches resulted in similar
parameter estimates. However, the standard error values were obtainable using the
linearization method with a faster CPU time. When the modified cell population
observations are ignored, the AIC value of 268.61 is smaller compared to the AIC of
the other two fits. Figure 3.7 we can see that the both of the fitting routines behaved
similarly where the points are not aligned with the 45o purple line except for the
memory stem cell population. This indicates that the model does not appropriately
fit the data very well. And this is evident in the individual fit Figure 3.8 where the
model curve does not pass through all the data points like in the memory stem cell
fit. The LN fitting routine, seems to pass through the data point better than the
LNM method. The zero values for the proliferation rates indicates that these cells
have increased to a level that cannot proliferate further.
Looking at Figure 3.8, we can draw the following observations about the dynamics
of the five CD4 T-cell subsets.
• The na¨ıve, memory stem cell and central memory cells increased in size.
• The transitional and effector cells exhibit no change.
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Param Lin-all s.e Stoch-all s.e Lin-non s.e
λ 14.6 1.1e+004 14.6 2.8 10.6 4.1e+005
pN 8.88e-007 31 8.88e-007 NaN 0.159 4.2e+004
pST 0.000107 2.4e+002 0.000107 0.00043 0.132 5.6e+005
pC 0.000641 13 0.000641 0.0021 0.000514 9.3e+004
pT 0.000305 53 0.000305 NaN 0.00117 1e+005
pE 0.332 62 0.332 0.075 0.0221 7e+003
φN 0.209 35 0.209 0.047 0.251 7.1e+003
φST 0.714 19 0.714 0.05 0.337 2.2e+005
φC 0.0862 15 0.0862 0.019 0.145 5.4e+003
φT 0.355 2.4e+002 0.355 0.09 0.638 3.2e+003
dN 9.98e-007 1.1e+002 9.98e-007 0.0017 0.000576 2.4e+004
dST 5.86e-009 6.9 5.86e-009 NaN 1.12e-005 5.9e+005
dC 0.00872 14 0.00872 0.018 5.98e-005 1.5e+005
dT 0.0407 2.6e+002 0.0407 0.038 0.00224 4.4e+004
dE 0.599 3.3e+002 0.599 0.085 0.9 1e+002
AIC 499.67 499.67 268.61
CPU (sec) 1.35e+003 2.36e+004 890
Table 3.6: This table illustrates the fits obtained from the three fitting approaches
with their AIC and standard error measurements for patient 203.
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Figure 3.7: Observed vs Prediction output for patient 203.
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Figure 3.8: Individual fits for the na¨ıve and memory CD4 T-cells for pat 203.
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Patient 302 - Medium Dose
Table 3.7 shows the parameter estimates for patient 302. Again, when using all the
10 cell populations experimental data points are used, the stochastic approximation
and model linearization approaches to calculate the Fisher Information matrix, result
in similar parameter estimates. However, using the model linearization approach,
the software was able to calculate the standard error with a shorter CPU time. The
s.e values and the AIC value of 268 are smaller when using only non modified cell
data points.
Figures 3.9, shows that the model is not well fitted to most of the cell populations,as
the points and the spline line does not align with the 45o purple line. However,
the third approach, where only the non modified cells observations are used, the
model was able to better fit the memory stem cell population which is evident as
the observations and the spline line were closer to the purple line.
From Figure 3.10, we can make the following observation about the change in the
memory and na¨ıve CD4 T-cell populations:
• The na¨ıve, memory stem and central have increased from the baseline.
• The effector and transitional memory cells have exhibit no change.
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Param Lin-all s.e Stoch-all s.e Lin-non s.e
λ 13.8 1.8e+006 13.8 NaN 13.6 6.1e+005
pN 0.173 3.3e+004 0.173 NaN 0.189 5.7e+003
pST 0.112 5.1e+004 0.112 NaN 0.0914 6.3e+004
pC 0.000947 2.7e+004 0.000947 NaN 0.00649 1.2e+004
pT 0.0472 5.3e+004 0.0472 0.4 0.00575 6.1e+003
pE 0.846 1.7e+004 0.846 NaN 0.274 8.6e+004
φN 0.144 1.7e+003 0.144 0.01 0.191 3.8e+002
φST 0.366 1.2e+004 0.366 0.081 0.459 3.7e+004
φC 0.277 3.1e+003 0.277 0.027 0.325 3.3e+002
φT 0.599 6.1e+002 0.599 0.16 0.832 1.3e+004
dN 5.78e-015 0.0042 5.78e-015 2.8e-010 0.000541 9.6e+002
dST 0.000387 3.4e+004 0.000387 NaN 0.00057 7.4e+004
dC 0.0449 3.8e+003 0.0449 NaN 0.106 2.8e+004
dT 0.266 1e+004 0.266 NaN 0.19 1e+004
dE 0.772 6.5e+003 0.772 0.13 0.796 4.1e+004
AIC 605.15 605.15 304.25
CPU (sec) 1.43e+003 7.44e+003 950
Table 3.7: This table illustrates the fits obtained from the three fitting approaches
with their AIC and standard error measurements for patient 302.
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Figure 3.9: Observed vs Prediction output for patient 302.
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Figure 3.10: Individual fits for the na¨ıve and memory CD4 T-cells for patient 302.
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Patient 201 - Medium Dose
Table 3.8 lists the three parameter fit approaches for patient 201. When all the
10 cell populations data observations are used, the model linearization was able to
capture a better fit than the stochastic approach with a sorter CPU time and a
slightly smaller AIC value 627.80.Comparing both column 1 and column 5, the fit
in column 5 had a smaller AIC value of 314, and smaller CPU time. The goodness
of fit is evident when looking at the individual fits in Figure 3.11 as the ODE curve
was closer to the data points.
Figure 3.12, shows that when using the non modified observations only, the spline
and the observations were most of the time closer to the purple 45o line.
From Figure 3.11, the na¨ıve and memory CD4 T-cells subsets have increased from
the baseline.
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Param Lin-all s.e Stoch-all s.e Lin-non s.e
λ 24.9 7.3e+002 15.9 4.2 20.4 1.1e+002
pN 1.03e-010 6 3.87e-012 NaN 1e-015 0.00096
pST 1.01e-010 9.5 1.75e-010 1.5e-007 0.528 1e+003
pC 0.0444 36 0.11 NaN 2.77e-014 0.026
pT 0.916 25 7.67e-007 NaN 5.96e-015 0.017
pE 1.46e-010 7.8 0.903 NaN 2.88e-013 0.54
φN 0.119 3.8 0.0754 0.02 0.0942 87
φST 0.567 16 0.285 0.12 0.0958 91
φC 0.0704 1.2 0.0231 0.0071 0.0912 5.3e+002
φT 0.125 6.4 0.101 0.029 0.262 1.1e+002
dN 3.45e-005 2 2.39e-014 NaN 0.00297 86
dST 6.46e-012 0.78 1.76e-011 NaN 0.000293 35
dC 5.34e-010 8.6 4.93e-013 8.1e-009 3.67e-005 6e+002
dT 4.03e-011 9.2 6.54e-005 NaN 0.0711 1.9e+003
dE 0.277 15 1.01e-005 NaN 0.617 2.5e+002
AIC 627.80 633.85 314.78
CPU(sec) 1.8e+003 3.03e+004 1e+003
Table 3.8: This table illustrates the fits obtained from the three fitting approaches
with their AIC and standard error measurements for patient 201.
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Figure 3.11: Individual fits for the 5 population of non modified CD4 T-cells for
patient 201.
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Figure 3.12: Observed vs prediction output for patient 201.
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Patient 303- High Dose
Table 3.9 shows the parameter estimates for patient 303. Again, when all the
10 cell populations data points are used, both model linearization and stochastic
approximation approaches to calculate the Fisher Information Matrix gave similar
parameters estimates. However, the model linearization method was less compu-
tationally expensive and s.e were obtainable. The AIC value when using only
non-modified cell population data points, the AIC value of 291.08 is half of that
other two fits, indicating it is a better fit. This result is also evident in the individual
fits Figure 3.13 as the ODE curve passes through most of the data points except for
the central memory cell population.
Figure 3.14, Shows that when using the non modified observations only, the spline
and the observations were laying on closer to the purple 45o line. From Figure 3.13,
we can see that all the cell populations have increased from the baseline except for
the central memory cell which decreased in size according to the model predictions.
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Param Lin-all s.e Stoch-all s.e Lin-non s.e
λ 32.5 2.6e+002 32.5 14 10.8 2.6e+002
pN 8.67e-034 NaN 8.67e-034 NaN 0.0119 6.3
pST 0.991 15 0.991 NaN 0.0112 1.9e+002
pC 2.17e-056 NaN 2.17e-056 NaN 0.00737 1.3e+003
pT 0.00736 13 0.00736 NaN 0.27 1.1e+003
pE 3.38e-012 0.075 3.38e-012 5.6e-008 0.0232 1.4e+003
φN 0.304 2.5 0.304 0.13 0.102 30
φST 0.628 2.6 0.628 0.18 0.118 16
φC 0.0803 0.68 0.0803 0.032 0.096 2e+002
φT 0.397 0.93 0.397 0.16 0.247 9.9e+002
dN 6.6e-053 NaN 6.6e-053 NaN 0.00559 27
dST 4.62e-077 NaN 4.62e-077 NaN 0.00538 1.2e+002
dC 0.333 2.4 0.333 0.1 0.444 1.1e+003
dT 1.85e-030 NaN 1.85e-030 NaN 0.018 49
dE 0.705 1.7 0.705 0.29 0.499 2.9e+003
AIC 681.23 681.23 293.08
CPU (sec) 4.74e+003 2.37e+004 2.18e+003
Table 3.9: Illustrates the fits obtained from the three fitting approaches with their
AIC and standard error measurements.
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Figure 3.13: Individual fits for the na¨ıve and memory CD4 T-cells for pat 303.
89
Figure 3.14: Observed vs prediction observation for pat 303.
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Patient 304 - High Dose
Table 3.10 shows the parameter estimates for patient 304. Again, using all the 10
cell populations data points in the fit, both the model linearization and stochastic
approximation approaches in calculating the Fisher Information Matrix, result in
similar parameter estimates and AIC values with having a smaller CPU using the
model linearization approach. Considering only the non-modified cell populations
the AIC value of 208.82 indicates it is a better fit. However, when looking at Figure
3.15, we can observe that both fits(LN and LNM) result in similar individual fits.
Figure 3.16, Shows that when using the non modified observations only, the spline
and the observations were most of the time closer to the 45o purple line, indicating
that our model was able to replicate the clinical study. From Figure 2.15, it is
evident that all the cell populations have increased from the baseline.
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Param Lin-all s.e Stoch-all s.e Lin-non s.e
λ 48.2 1.9e+004 48.2 15 14.3 7.4e+003
pN 6.57e-013 17 6.57e-013 2e-009 0.224 52
pST 4.84e-011 6.1e+002 4.84e-011 NaN 0.672 1.8e+002
pC 8.4e-013 18 8.4e-013 NaN 3.74e-014 0.11
pT 4.09e-011 2.3e+002 4.09e-011 NaN 1.87e-016 0.00031
pE 3.38e-012 0.075 1.69e-010 4.4e-007 0.0232 1.4e+003
φN 0.304 2.5 0.532 0.18 0.266 52
φST 0.628 2.6 0.981 0.022 0.618 1.4e+002
φC 0.0803 0.68 0.265 0.083 0.266 27
φT 0.491 1.4e+002 0.491 0.31 0.399 41
dN 7.29e-012 32 7.29e-012 1.6e-008 9.99e-017 0.00024
dST 1.93e-012 69 1.93e-012 7.6e-009 2.08e-023 NaN
dC 1.08e-010 1.3e+002 1.08e-010 NaN 0.444 1.1e+003
dT 7.3e-006 2.8e+002 7.3e-006 NaN 1.94e-019 NaN
dE 0.996 1.9e+002 0.996 0.0042 0.997 1e+002
AIC 364.49 364.49 208.82
CPU(sec) 4.28e+003 1.56e+004 2.84e+003
Table 3.10: Illustrates the fits obtained from the three fitting approaches with their
AIC and standard error measurements for patient 304.
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Figure 3.15: Individual fits for the na¨ıve and memory CD4 T-cells for patient 304.
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Figure 3.16: Observed vs prediction for patient 304.
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Patient 305- High Dose
Table 3.11 shows the parameter estimates for patient 305. Similar to the patients
above, fits obtained from using both a stochastic approximation or model lineariza-
tion to calculate the Fisher Information Matrix had similar parameter values. Using
When only non-modified cell populations the AIC value of 232.66 is the smallest
compared to all the other fits.
The three fitting routines results in having a zero value for the memory stem cell
death rate dST . This indicates that the death rate of the memory stem cell became
negligible after the treatment. When the first two fitting routines failed to estimate
the proliferation rates for most of the cell populations, the third one was able to do
so. Looking at Figure 3.17, we can see that the na¨ıve, central and effector cells had
a good fit where the ODE curve passed through most of the data points. Figures
3.18 shows that the na¨ıve and effector cell data points are closer to the 45o purple
line which means that the fit for these population was good. From Figure 3.17 we
can conclude the following:
• The na¨ıve and transitional memory cells decreased in cell count.
• The memory stem and effector cells increased in count.
• The transitional memory cell exhibit no change.
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Param Lin-all s.e Stoch-all s.e Lin-non s.e
λ 12.56407 61 12.56407 8.5 8.96240 1.1e+006
pN 0 0.064 0 7.5e-011 0.07369 6.2e+004
pST 0 0.29 0 2.2e-010 0.00396 7e+004
pC 0 0.022 0 5.6e-011 0 0.039
pT 0 0.21 0 6.6e-010 0.00141 5.7e+005
pE 0.08672 4.1 0.08672 0.16 0.02939 1.3e+006
φN 0.13401 0.77 0.13401 0.075 0.13602 1.3e+003
φST 0.51269 3.8 0.51269 0.58 0.48367 4.8e+004
φC 0.12176 1.5 0.12176 0.06 0.12000 2.3e+005
φT 0.31359 4.8 0.31359 0.31 0.32529 9.1e+005
dN 0 0.21 0 2.1e-010 0.00918 3.2e+004
dST 0 0.8 0 1.9e-009 0 0.046
dC 0.00082 2 0.8 0.00082 0.00148 2.3e+005
dT 0.01461 8.4 0.01461 0.16 0.01267 1.4e+006
dE 0.31986 6.1 0.31986 0.3 0.31500 1.7e+006
AIC 450.60 448.60 232.66
CPU(sec) 4.13e+003 1.56e+004 2.48e+003
Table 3.11: Illustrates the fits obtained from the three fitting approaches with their
AIC and standard error measurements for patient 305.
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Figure 3.17: Individual fits for the na¨ıve and memory CD4 T-cells for patient 305.
97
Figure 3.18: Observed vs prediction outputs for patient 305.
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3.4 Parameter identifiablity, Over-fitting issues and Algo-
rithm Convergence
One of the most common problems in complex biological models is that some
parameters cannot be estimated by fitting the simplest proposed model. Using all
the fitting routines in Monolix and Stan, we have faced several fitting problems
where even if the parameters were identifiable they were not properly estimated and
some parameters were not identifiable using the clinical data measurements.
When fitting the observations to our dynamical model, we had some parameters
that were not identifiable such as the proliferation rates in some patients. This was
evident in both the fits done in Monolix and Stan. These fitting issues could be a
result of the assumptions we made when describing the transition from the na¨ıve to
the effector memory state as linear. In addition, in some cell populations for some
patients, we had the over fitting issue where the number of unknown parameters
exceeded the number of observations. The model specification was evident in the
prediction vs observed Figures (3.3,3.5,3.7,3.9,3.12,3.14,3.16,3.17) where the spline
and the data points were not always aligned with the 45o line. This indicates that
the model was not able to successfully replicate the clinical study.
An additional complication includes the fact that the fitting algorithm may get
stuck in a local minimum or maximum rather than the global one. And, as we have
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no prior knowledge about the parameters, it was challenging to give a closest initial
guess in order to get a better fit.
In conclusion, we have seen that using the model linearization of the Fisher Informa-
tion Matrix to calculate the standard error was the most suitable method. Restricting
our model to the non-modified na¨ıve and memory CD4 T-cell, the model was able
to capture the data more successfully as it resulted in having smaller AIC values.
As well, the observed vs prediction graphs showed that when ignoring the modi-
fied cell population, the data points were closer to the 45o line, indicating a better fit.
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4 Sensitivity and Uncertainty Analysis
4.1 Introduction
In chapter 3, we have presented several parameter estimation results using
various fitting techniques. It is of interest to determine which parameters most
affect the T-cell count at different observation points. We now use sensitivity and
uncertainty analysis to determine such importance. In this chapter, using both
Latin Hypercube Sampling (LHS) and Partial Rank Correlation Coefficient values
(PRCC), we will explore the effect of each of the fifteen model parameters on the
five na¨ıve and memory CD4 T-cells along with the total CD4 T-cell counts over 200
days after the initiation of the treatment for each of the three cohorts. This chapter
is organized as follow:
• In section 3.1 we will introduce the LHS and PRCC concepts.
• In section 3.2, we will present the observed changes in the proliferation, death
and transition rates from baseline. Moreover, we will investigate the relative
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significance of each of the model parameters in relation to each of the na¨ıve
and memory CD4 T-cell population size using the PRCC values.
4.2 Uncertainty Sensitivity Analysis: LHS and PRCC
LHS
Latin Hypercube Sampling, first proposed by Mckay in 1979, is a statistical sampling
method that belongs to the Monte Carlo class of sampling method [41]. It is a
stratified sampling without replacement techniques. Using a sample size N, the
algorithm partitions the random parameter distributions into N equally probability
intervals independently. A Latin Hypercube Sampling matrix is generated that
consists of N rows and k columns, where k is the number of parameters and N is
the number of run or simulations[41].
Partial Rank Correlation Coefficient- PRCC and Sensitivity Analysis
The PRCC is a correlation coefficient in statistics, known to measure the strength
of the linear association between a given input xj and an output y. It is defined by
the ratio between the covariance of xjy and sqrt of the product of the variance of
xj and y as illustrated in the equation below:
CC =
COV (xjy)√
V ar(xj)V ar(y)
(4.1)
The PRCC value vary between -1 and +1, where -1 indicating a strong negative
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correlation and the +1 a strong positive correlation. Any correlation less than
+0.5 and greater than -0.5 is assumed to be a non significant correlation [41]. A
positive correlation indicates that as we increase the model parameter the output will
increase and similarly a negative indicates that as we increase the model parameter
the output will decrease. Combining both of the PRCC and LHS, we are able
to draw some conclusions about the significance of some unknown parameters on
specific model outputs.
4.3 Sensitivity Analysis
In Chapter 3, results of the parameter estimations, have presented the fits
obtained before the initiation of the treatment (at baseline), and the ones obtained
after the initiation of treatment. The best two fits obtained from the Monolix and
the fit obtained from the Stan software will be used in this section, in order to
highlight any significant changes in the parameter values. This will better inform us
how the perturbation by the CCR5-down-modulated memory CD4 T-cell affected
any of the five na¨ıve and memory CD4 T-cell sub-populations behaviors (birth,
death, proliferation and transition). Later, using the PRCC values obtained by the
sensitivity analysis, we analyze the correlation between the model parameters and
each of the na¨ıve, memory stem, central, transitional, effector and total memory
CD4 T-cells using the deterministic model given by the Eq’s 2.1 and 2.2. In this
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work, we will explore the time dependent significance of the fifteen model parameters
on the five na¨ıve and memory CD4 T-cell subsets count over the course of 200
days. We have picked 200 days for these simulations as we have seen that the
system populations reach a steady state approximately 80 days post initiation of
the clinical trial. The PRCC variables are the fifteen model parameters and the
output are the na¨ıve, stem, central, transitional, effector and total memory CD4
T-cells. Throughout this work, we defined the total count for the na¨ıve and memory
CD4 T-cells as the sum of all the five sub-populations at time, t.
We used 10000 bins to run the LHS code in Matlab for all of the nine patients.In
this work we will consider that any PRCC values smaller than 0.5 or bigger than
-0.5 is said to be not significant[41]. A positive correlation indicates that the model
variables and the output have a proportional relationship. This means that as
we increase the parameter value the output will increase. A negative correlation
indicates that the model parameter and the output have an inverse proportional
relationship. This indicates that an increase in the parameter will yield to a decrease
in the output. Throughout this chapter, we will be using the symbols to refer to
each of the fifteen parameters as illustrated in Table 2.2.
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4.3.1 Low Dose Cohort
The low dose cohort represents the three patients that received a single infusion
of autologous CCR5-modified (SB-728-T) 1.0 x 1010 cells. All of the baseline
measurements are measured seven days prior to the infusion of the CCR5 modified
T-cells. The three patients had a mixed range of CD4 T-cell at baseline that varied
between low, medium and high levels.
4.3.1.1 Patient 103
At baseline, this patient had the lowest count of 188 CD4 T-cell per µL. Looking
at table 4.1 we can note the following observations about each of the five sub-
population behaviors:
• The number of na¨ıve CD4 T-cells λ produced by the thymus decreased.
• The proliferation rates for the central memory pC and transitional memory pT
increased. The proliferation rate of the effector memory cells pE has increased
by one order of magnitude.
• The transition rates for all of the cells remained the same except for the
transition rate of the transitional memory cell φT that had a slight increase.
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• The death rates for the na¨ıve dN and stem memory cells dST have decreased
by one order of magnitude. This means that their lifespans have increased
considerably by 100 days.
• The death rates for the central memory dC , transitional memory dT and
effector memory dE cells have increased slightly.
As for the sensitivity analysis obtained over 200 days we observe the followings from
Figures 4.1, 4.2 and 4.3:
Na¨ıve Cell:
In Figures 4.1, we can see that although the thymic production rate λ has a signif-
icant effect soon after the treatment, but this effect started to fade 20 days post
treatment. The proliferation rate of the na¨ıve cell pN , has a significant positive
correlation with the na¨ıve cell population. However, the transition rate φN has a
negative correlation, where if the na¨ıve cells transition to the memory stem cell
in a higher rate the number of the na¨ıve cell will decrease. These findings are
expected as we had a decrease in the death rate dN , thus the proliferation rate pN is
able to exhibit a positive correlation that results in an increase in the na¨ıve cell count.
Memory Stem cell
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The na¨ıve cell proliferation rate pN has a positive correlation with the memory stem
cell count. This could be explained by the fact that as the number of the na¨ıve cell
increase, a higher number of na¨ıve cells are going to transition to the memory stem
cell state. The transition rate of the transitional memory cell φST has a positive
correlation. Moreover, for the first 20 days post treatment, the effector memory cell
death rate dE had a positive correlation with the memory stem cell count. This
result could indicate a possible transition between the effector, transitional memory
cell and the memory stem cells. Finally the transition rate of the memory stem
cell population φST has a negative correlation with the stem cell population count
which is an expected correlation as the more the cells leave the memory stem state
its population count will decrease.
Central Memory Cell
The central memory cells had similar results to the memory stem cell population
where the na¨ıve proliferation rate pN had a positive correlation. This could indicate
a possible backward transition between the memory stem and central memory cells.
Similarly to the above cell populations, the transition rate of central memory cells
phiC has a negative correlation with the central memory population count.
Transitional Memory cell
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Consistent with the results of memory stem and central memory cells, proliferation
of na¨ıve cells pN is positively correlated with transitional cell population. Similarly
the transition rate of the transitional memory cell population φT is negatively
correlated with its cell population which indicates that the more the cells are leaving
the transition state the lower the population count is becoming.
Effector Memory cell
Similarly, the effector cells were positively correlated with the na¨ıve cell proliferation
rate pN . As for the first 50 days post injection of the down-modulated memory CD4
CCR5 cells, both the transition rates of the transitional memory φT and central
memory cells φC have a positive correlation with the effector memory cell population.
This indicates that the transitional and central memory cells play an important role
in increasing the effector memory cells population count. Lastly, the death rate of
the effector memory cell dE has a significant negative correlation with the effector
memory cell count. This result is consistent with the parameter estimation as the
effector memory cell death rate increased after the initiation of the clinical trial in
this patient.
Total na¨ıve an memory CD4 T-cell
The total number of na¨ıve and memory CD4 T-cells were negatively correlated
with the na¨ıve cell transition rate φN and positively correlated with the na¨ıve cell
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proliferation rate pN and the effector memory cell death rate dE. This indicates that
for patient 103, the na¨ıve cell population plays an important role in the reconstitution
of the total CD4 T-cell. Furthermore, an increase in the effector memory cell death
dE can indicate a possible increase in their activity against the HIV virus.
Parameters Baseline Non-modified T-cell SATN fit Min-Max
λ 9.171294443 6.13933 2.7117 2.7117-9.1712
pN 0.001154901 0.000201 0.0109 0.000201-0.0109
pST 0.011031316 0.00640 0.2590 0.0064-0.2590
pC 0.010900323 0.08209 0 0-0.09
pT 0.021644028 0.06390 0.0887 0.021644-0.0976
pE 0.033551917 0.41340 0 0-0.483
φN 0.215314186 0.21732 0.0973 0.0973-.21732
φST 0.463596696 0.46060 0.3590 0.3590-0.46359
φC 0.105280147 0.11722 0.0373 0.0373-0.117
φT 0.247796071 0.33989 0.1886 0.18866-0.33989
dN 0.01040803 0.00608 0.0136 0.00565-0.0136
dST 0.01108572 0.00685 0 0-0.011085
dC 0.003333333 0.00564 0.0627 0.00249-0.0627
dT 0.023361168 0.03274 0 0-0.03274
dE 0.375021515 0.49776 0.1 0.1-0.49776
Table 4.1: Illustrates the data fitting results and the range used in the LHS for pat
103. These values are the rates per day−1.
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Figure 4.1: Correlation between the N, STM T-cell and the 15 parameters over 200
days for pat 103.
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Figure 4.2: Correlation between the CM and TM T-cell and the 15 parameters over
200 days for pat 103.
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Figure 4.3: Correlation between the EM and total CD4 T-cell and the 15 parameters
over 200 days for pat 103.
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4.3.1.2 Patient 102
At baseline, this patient had a somewhat high count of 439 CD4 T-cell per µL.
Looking at Table 4.2 we can note the following observations about each of the five
sub-population behaviors:
• The number of na¨ıve CD4 T-cells produced by the thymus λ increased.
• The proliferation rates for the na¨ıve pN , memory stem pST and effector memory
cells pE increased by one order of magnitude.
• The proliferation rates for the transitional memory cell pT decreased by one
order of magnitude.
• The transition rate of the central memory cells φC decreased by one order of
magnitude.
• The transition rate of the memory stem cell φST increased by half its value.
• The death rates for the na¨ıve dN and stem memory celldST decreased by one
order of magnitude. This indicates that their lifespan increased by 100 days
considerably.
• The death rate for the effector memory cell dE increased by one order of
magnitude.
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As for the sensitivity analysis obtained over 200 days we observe the followings from
Figure 4.4 and 4.5 and 4.6:
Na¨ıve Cell:
The sensitivity analysis agrees well with the parameters estimations results presented
in Table 4.2. The parameters λ and pN have a positive correlation with the number
of na¨ıve cell population. The transition rate of the na¨ıve cell φN has a negative
correlation.
Memory Stem cell
While the na¨ıve cell thymic production rate λ, and both the memory stem pST and
na¨ıve cell proliferation pN rates are positively correlated with the memory stem cell
population, the transition rate φST has a negative correlation. This indicates that
the na¨ıve cells play an important role in the memory stem cell population.
Central Memory Cell
The importance of the na¨ıve cell production rate from the thymus λ continues
to exhibit a positive correlation with the central memory cell population in this
patient. The proliferation rate for the na¨ıve pN and memory stem cell pST started
to display a positive correlation with the central memory cell population about 30
days post injection of the clinical trial. This could be justified by the delayed effect
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of the modified memory CD4 T-cell, as before the treatment patient 102 had a low
proliferation rates for the na¨ıve pN and memory stem cell populations pST . Both
the death and transition rates for the central memory cells dC , φC have a negative
effect on the central memory cell count.
Transitional Memory cell
Similar to the na¨ıve cell production rate λ, along with the na¨ıve and memory stem
cell proliferation rates pN and pST have a positive effect on the transitional cell
population count. Moreover, the transition rate of the central memory cell φC has a
positive correlation as well, indicating the importance of the central memory count
in replenishing the transitional memory cell population, which explains the negative
correlation between the central memory cell death rate dC and the transitional
memory cell population. Finally, as the proliferation rate pT decreased after the
infusion of the modified memory CD4 T-cells, the transition rate of the transitional
cell φT displayed a negative correlation with the transitional memory cell population.
Effector Memory cell
The importance of the na¨ıve, memory stem and central memory cells persist as well
in the effector memory cell count. This is shown by the positive correlation of the
na¨ıve cell production rate λ, the central memory cell transition rate φC and prolif-
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eration of both the na¨ıve pN and memory stem pST cell with the effector memory
cell population. In addition to the above positive correlations, the importance of
the central memory cells is evident in the negative correlation between the central
memory death rate dC and the effector memory cell population. These observations
indicate that the central memory, na¨ıve and memory stem cell play an important
role in the effector memory cell population. As the death rate of the effector memory
cell dE has a significant increase, its negative correlation with the effector memory
population is also observed.
Total na¨ıve an memory CD4 T-cell
The important effect of the na¨ıve and memory stem cells on the replenishment of
the total number of CD4 T-cell is apparent by the positive correlation of the na¨ıve
cell production rate λ, along with the proliferation rates of both the na¨ıve pN and
memory stem cell pST . This justifies the negative correlation between the transition
rates of the memory stem cell φST , na¨ıve cell φN and the central memory cell φC
with the total number of CD4 T-cells. Lastly, the death rate of the central memory
cell dC was negatively correlated with the total number of CD4 T-cell illustrating
the importance of the central memory cell. These results indicates that the memory
stem cell, central memory and na¨ıve cell play an important role in increasing the
total number of CD4 T-cell population.
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Parameters Baseline Non-modified T-cell SATN fit max-min
λ 9.171294443 13 7.4924 7.4924-18.2
pN 0.001154901 0.087105 0.0200 0.0011549-0.0871
pST 0.011004862 0.10033 0.1375 0.01100-0.159
pC 0.010980541 0.03179 0 0-0.0511
pT 0.021644028 0.0018056 0.0880 0.000167-0.0880
pE 0.033551917 0.18993 0 0-0.268
φN 0.215314186 0.19645 0.1171 0.1171-0.227
φST 0.463596696 0.23481 0.2375 0.235-0.463596696
φC 0.105280147 0.096345 0.0281 0.0281-0.10528
φT 0.247796071 0.36969 0.1880 0.1880-0.319
dN 0.01040803 0.0071514 0.0028 0.0028-0.010408
dST 0.01108572 0.004742 0 0-0.011085
dC 0.003333333 0.004742 0.0719 0.00333-0.0719
dT 0.023195675 0.020894 0 0-0.0408
dE 0.09096808 0.31554 0.1 0.0909-0.31554
Table 4.2: Illustrates the data fitting results for pat 102 along with the PRCC range.
These values are the rates per day−1.
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Figure 4.4: Correlation between the N and STM T-cell and the 15 parameters over
200 days for pat 102.
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Figure 4.5: Correlation between the CM and TM T-cell and the 15 parameters over
200 days for pat 102.
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Figure 4.6: Correlation between each the EM and total CD4 T-cell and the 15
parameters over 200 days for pat 102.
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4.3.1.3 Patient 104
At baseline, this patient had a low count of 261 CD4 T-cell per µL. Looking
at Table 4.3 we can note the following observations about each of the five sub-
population behaviors:
• The number of na¨ıve CD4 T-cells produced by the thymus λ slightly increased.
• The proliferation rates for the na¨ıve pN , memory stem pST and central memory
cells pC have decreased.
• The transition rates for the na¨ıve φN , memory stem φSTand central memory
cells φC decreased by one or two order of magnitude.
• The death rate for the memory stem cell dST decreased by one order of
magnitude. In addition, the death rates for both the na¨ıve pN and transitional
memory cells pT slightly decreased.
• The central memory dC and effector memory cells dE have a doubled death
rate from baseline.
As for the sensitivity analysis obtained over 200 days we observe the following from
Figure 4.7, 4.8 and 4.9:
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Na¨ıve Cell:
While the thymic production rate λ has a positive correlation with the na¨ıve cell
population, the na¨ıve cell transition rate φN has a negative correlation.
Memory Stem cell
Whereas the thymic production rate λ and the memory stem cell proliferation pST
rate both display a positive correlation with the memory stem cell population, the
transition rate of the stem cell φST had a negative correlation. As the memory stem
cell death rate dST decreased by one order magnitude after the initiation of the
clinical trial, it was expected that a negative correlation with the memory stem cell
population would be observed.
Central Memory Cell
The significant effect of the thymic production rate λ on the central memory cell
population is not detected as the PRCC value is 0.4 indicating a trivial positive
correlation. This is due to the low increase in λ. The proliferation rate of the central
memory cell pC and the transitional cell transition rate φT both display a positive
correlation with the central cell population. The death rate of the central memory
cell dC have a negative correlation with the central memory cell as the death rate
increased after the initiation of the treatment.
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Transitional Memory cell
Proliferation rates of both the transitional memory pT and central memory cell pC
were positively correlated with the the transitional cell population. The central
memory death rate dC is shown to have a negative correlation with the transitional
cell population. However, as the death rate of the transitional cell dT did not exhibit
any change after the initiation of the treatment it did not have any significant
negative correlation with the transitional memory cell population. In addition, the
transition rate of the transitional cell φT displays a negative correlation with the
transition cell population.
Effector Memory cell
Both the central dC and effector memory cells dE death rates have a significant
negative correlation with the effector memory cell population as these rates increased
after the introduction of the down modulated CCR5 CD4 T-cells. The proliferation
rates of both the central memory pC and transitional memory pT cell display a
positive correlation with the effector cell population. These results highlight the
importance of both the transitional and central memory cells on the reconstitution
of the effector memory cell population.
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Total na¨ıve an memory CD4 T-cell
The central memory cell population is shown to play an important role in most of
the memory CD4 T-cell populations as illustrated above. Hence, it is expected that
we continue to observe such importance in the total number of CD4 T-cell. The
sensitivity analysis highlights the importance of the central memory cell population
on the reconstitution of the CD4 T-cell where the proliferation rate of the central
memory cell pC is positively correlated with the total number of CD4 T-cell and
the central memory cell death rate dC has a negative correlation.
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Parameters Baseline Non-modified T-cell SATN fit max-min
λ 7.696589511 8.73264 6.4731 6.4731-9.44
pN 0.001155414 0 0.0413 0-0.0413
pST 0.010973075 0.00551 0.0213 0.004171-0.0213
pC 0.051117 0.0036500 0 0-0.05117
pT 0.021644028 0.00181 0.0590 0.00181-0.0590
pE 0.033596587 0.01390 0 0-0.03359
φN 0.267280553 0.12537 0.1401 0.125-0.26728
φST 0.467331743 0.00679 0.1158 0.00679-0.467331
φC 0.105280147 0.07149 0.0256 0.0256-0.10258
φT 0.249489254 0.32044 0.1584
dN 0.008914073 0.00261 0.0012 0.0012-0.008914
dST 0.01108572 0.00836 0.0054 0.0054-0.011085
dC 0.003333333 0.0715 0.0744 0.003333-0.0744
dT 0.023187029 0.01873 0.0007 0.0007-0.01873
dE 0.288952838 0.47502 0.1 0.1-0.47502
Table 4.3: Illustrates the data fitting results for pat 104. These values are the rates
per day−1.
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Figure 4.7: Correlation between the N and STM T-cell and the 15 parameters over
200 days for pat 104.
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Figure 4.8: Correlation between the CM and TM T-cell and the 15 parameters over
200 days for pat 104.
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Figure 4.9: Correlation between the EM and total CD4 T-cell and the 15 parameters
over 200 days for pat 104.
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4.3.2 Medium Dose Cohort
The Medium dose cohort represents the three patients that received a single
infusion of autologous CCR5-modified (SB-728-T) 2.0 x 1010 cells. All of the baseline
measurement are measured seven days prior to the infusion of the CCR5 modified
T-cells.
4.3.2.1 Patient 203
At baseline, this patient had a low count of 294 CD4 T-cell per µL. Looking
at Table 4.4 we can note the following observations about each of the five sub-
population behaviors:
• The number of na¨ıve CD4 T-cells produced by the thymus λ did not have a
large increase.
• While the proliferation rates for the na¨ıve pN and memory stem pST increased
by at least one order of magnitude, the proliferation for the rest of the memory
CD4 T-cell subsets decreased.
• The transition rate for the transitional memory cell φT has a significant
increase.
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• The death rate for the na¨ıve dN , memory stem cell dST , central dC and
transitional memory cells dT have a very significant decrease.
• The effector memory cell death rate dE doubled.
As for the sensitivity analysis obtained over 200 days we observe the followings from
Figure 4.7 and 4.8:
Na¨ıve Cell:
Similar to patient 104, the na¨ıve cell population was positively correlated with the
na¨ıve cell production rate λ and negatively correlated with the na¨ıve cell transition
rate φN . It is important to mention that patients 104 and 203 have similar baseline
count of the CD4 T-cell before they received the experimental treatment. As the
death of the na¨ıve cell dN did not experience any significant change after the initia-
tion of the clinical trial, in the sensitivity analysis we observed that it did not have
any significant correlation rate with the na¨ıve cell population.
Memory Stem cell
The na¨ıve cell production rate λ display a positive correlation with the stem cell
population. The transition rate of the na¨ıve cell φN has a positive correlation only
for the first 30 days post treatment. This observation could be justified by the fact
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that the transition rate of the na¨ıve cell population did not exhibit any significant
increase post treatment. The memory stem cell transition rate φST is negatively
correlated with its cell count. The death rate of the memory stem cell dST did not
show any negative correlation as this rate decreased notably from baseline.
Central Memory Cell
The na¨ıve cell production rate λ maintains its positive correlation even with the
central memory cell population. Similarly both the transition rates for the na¨ıve
φN and memory stem cell φST were only positively correlated for 30 days post
treatment. This is a valid observation as both of those transition rates did not
have any significant increase from the baseline. The transition rate of the central
memory cell φC had a negative correlation with its population. The death rate
dC did not express any negative effect as it decreased after the introduction of
the down modulated CCR5 CD4 T-cells. The transitional and effector memory
population have similar results to the central memory cells. However, the death
rate of the effector memory cell dE showed a strong negative correlation with the
effector memory cell population as this rate increased notably after the infusion of
the modified CD4 T-cell.
Total na¨ıve an memory CD4 T-cell
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As a result of the above observations, only the production rate of the na¨ıve cell by
the thymus λ has a positive effect on the reconstitution of the total number of CD4
T-cell. The transition rates for central memory φC and na¨ıve cells φN had a strong
negative correlation with the total CD4 T-cell count. This indicates that the central
memory and na¨ıve cell population are the main sub-populations that contribute
to the total CD4 T-cells in this patient. Even though patients 203 and 104 had a
similar CD4 T-cell count at baseline, both had different outcomes when it came to
the importance of the central memory and na¨ıve cell on the reconstitution of the
total number of CD4 T-cell. While for patient 104, who had half of the modified CD4
T-cell dose compared to patient 203, the central memory cell played an important
role in the total CD4 T-cell, as the proliferation rate for the central memory cellpC
was very small. However, this patient had a significantly higher increase compared
to the one from the low dose cohort. This indicates the importance of having a
higher dose of modified CD4 T-cell injected.
132
Parameters Baseline Non-modified T-cell SATN fit max-min
λ 9.108148985 10.6 6.94229 6.94229-10.28664
pN 0.0011482771 0.159 0.0094 0-0.18386
pST 0.011020353 0.132 0.1243 0-0.1243
pC 0.010895753 0.000514 0 0-0.01089
pT 0.021563362 0.00117 0.0030 0-0.144
pE 0.033205325 0.0221 0 0-0.033205
φN 0.164397745 0.251 0.1041 0.1041-0.251
φST 0.464899662 0.337 0.2243 0.2243-0.751
φC 0.105562369 0.145 0.0225 0.0225-0.145
φT 0.249269451 0.638 0.0780 0.07801-0.638
dN 0.010241378 0.000576 0.0080 0.000576-0.10241
dST 0.011141735 0 0 0-0.011141
dC 0.003333333 0 0.0775 0-0.0775
dT 0.023361168 0.00224 0.0249 0.00224-0.0667
dE 0.375021515 0.0221 0.1 0.1-0.0221
Table 4.4: Illustrates the data fitting results for pat 203 and the PRCC ranges.
These values are the rates per day−1.
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Figure 4.10: Correlation between the N and STM T-cell and the 15 parameters over
200 days for pat 203.
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Figure 4.11: Correlation between the CM and TM T-cell and the 15 parameters
over 200 days for pat 203.
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Figure 4.12: Correlation between the EM and total CD4 T-cell and the 15 parameters
over 200 days for pat 203.
136
4.3.2.2 Patient 201
At baseline, this patient had the highest count of 525 CD4 T-cell per µL com-
pared to the other eight patients. Looking at Table 4.5 we can note the following
observations about each of the five sub-population behaviors:
• The number of na¨ıve CD4 T-cells produced by the thymus,λ doubled in count.
• The proliferation rates for the na¨ıve pN , central memory pC , transitional
memory pT and effector memory cells pE decreased.
• The proliferation rates for the memory stem cell pST increased by one order
of magnitude.
• The transition rates for the memory stem φST and central memory cells φC
decreased by one order of magnitude.
• The death rate of the na¨ıve dN , memory stem dST and central memory cells
dC decreased by one order of magnitude.
• The death rate of the effector memory dE and transitional memory cells dT
increased.
As for the sensitivity analysis obtained over 200 days we observe the followings from
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Figure 4.13, 4.14 and 4.15:
Na¨ıve Cell:
Similar to patient 203, the production rate of the na¨ıve cell from the thymus λ had
a positive correlation with the na¨ıve cell population. Only the na¨ıve cell transition
rate φN had negative correlation on the na¨ıve cell population count. The death rate
dN did not have any effect as it decreased significantly after the treatment initiation.
Memory Stem cell
The na¨ıve cell production rate λ started to show a significant effect on the memory
stem cell count about 50 days post treatment. The na¨ıve cell transition rate φN had
a positive correlation with the memory stem cell population for only about 50 days
post treatment. This is because the na¨ıve cell transition rate did not increase by
much after the initiation of the clinical study. The memory stem cell proliferation
rate pST showed a negative correlation with the memory stem population. Death rate
of the memory stem cell dST did not show any negative correlation as it decreased
notably after the introduction of the down-modulated CCR5 CD4 T-cells.
Central Memory Cell
Likewise, the central memory cells show a similar result to patient 203 where the
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transition rates of both the na¨ıve φN and memory stem φST cells had a positive
correlation with the central memory cell count for about 20 and 50 days respectively.
In addition, the central memory cell transition rate φC exhibits a negative correlation.
Death rate of the central memory cell dC did not show any negative correlation as it
did have a significant decrease after the introduction of the down-modulated CCR5
CD4 T-cells as shown in the parameter estimation results.
Transitional Memory cell
The central memory cell death rate dC and the transition rate of the transitional
memory cell φT both had a negative correlation with the transitional memory cell
population. In addition, the na¨ıve cell production rate from the thymus λ along
with the transition rate of the central memory cell φC were positively correlated
with the transitional memory cell population. This indicates the importance of the
central memory cell on the transitional memory cell population.
Effector Memory cell
While the na¨ıve cell production rate λ, started to show a significant positive correla-
tion (PRCC greater than 0.5) about 80 days post injection of the treatment, the
significant positive correlation of the transitional memory cell started to decrease
about 80 days post treatment. The transition rates for both the na¨ıve φN and central
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memory cell φC had a strong positive correlation with the effector memory cell
count. The death rate of the na¨ıve cell dN started to exhibit a negative correlation
with the effector cell population 30 days post treatment initiation. These results
indicates that the na¨ıve and central memory cells play a very important role in the
reconstitution of the effector memory cell population.
Total na¨ıve an memory CD4 T-cell
The sensitivity analysis results carried on the total number of CD4 T-cell for patient
201 emphasizes the importance of the na¨ıve and central memory cell populations
on the reconstitution of the total CD4 T-cell count. This was illustrated in the
negative correlation between the central memory cell death rate dC and the na¨ıve
cell transition rate φN on the total CD4 T-cell count. In addition the na¨ıve cell
production rate λ had a positive correlation on the total CD4 T-cell count. It is
essential to mention that this patient had the highest count of the total CD4 T-cell
after three years post treatment between all the nine patients.
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Parameters Baseline Non-modified T-cell SATN fit min-max
λ 10.92205104 20.36874 19.3183 10.92205-24.9
pN 0.001137926 0 0.0576 0-0.0576
pST 0.011052071 0.52791 0.0012 0-0.52791
pC 0.011060716 0 0 0-0.044
pT 0.021671103 0 0.0155 0-0.916
pE 0.033205324 0 0 0-0.0332
φN 0.074641585 0.09417 0.1576 0.0746-0.1576
φST 0.464899665 0.09583 0.0984 0.09583-0.567
φC 0.102277319 0.09125 0.0276 0.0271-0.102227
φT 0.244401048 0.26178 0.0429 0.0429-0.262
dN 0.011824865 0.00297 0 0-0.01182
dST 0.011087322 0.00029 0.0058 0-0.01108
dC 0.003333333 0.00004 0.0724 0.00004-0.0724
dT 0.023222656 0.07113 0.0571 0-0.07113
dE 0.44672007 0.61700 0.1 0-0.617
Table 4.5: Illustrates the data fitting results for pat 201 and the PRCC ranges.
These values are the rates per day−1.
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Figure 4.13: Correlation between the N and STM T-cell and the 15 parameters over
200 days for pat 201.
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Figure 4.14: Correlation between the CM and TM T-cell and the 15 parameters
over 200 days for pat 201.
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Figure 4.15: Correlation between the EM and total CD4 T-cell and the 15 parameters
over 200 days for pat 201.
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4.3.2.3 Patient 302
At baseline, this patient had a high count of 413 CD4 T-cell per µL. Looking
at Table 4.6 we can note the following observations about each of the five sub-
population behaviors:
• The number of na¨ıve CD4 T-cells produced by the thymus λ had a slight
increase.
• The proliferation rates for the na¨ıve pN and memory stem cell pST increased
by one order of magnitude.
• The transition rate for the na¨ıve φN and transitional memory cell φT increased.
• The death rate of the na¨ıve dN , stem memory dST , central memory dC and
transitional memory dT cells decreased.
• The death rate of the effector memory cells dE increased.
As for the sensitivity analysis obtained over 200 days we observe the followings from
Figure 4.16, 4.17 and 4.18:
na¨ıve Cell:
Similar to patient 201, while λ had a strong positive correlation with the na¨ıve cell
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population, the transition rate of the na¨ıve cell φN has a negative correlation. The
death rate dN did not exhibit any negative correlation as this rate decreased after
the injection of the down-modulated CCR5 CD4 T-cell.
Memory Stem cell
Similar to patient 201, the memory stem population is positively correlated with
λ, and for the first 30 days post treatment the na¨ıve cell transition rate φN shows
a significant positive effect on the memory stem cell population. The stem cell
transition rates φST and death rate dST both have a negative correlation on the
stem memory cell count.
Central Memory Cell
The na¨ıve cell production rate λ started to have a positive correlation on the central
memory cell population at about twenty days post treatment initiation. While the
memory stem cell transition rate φC has a positive correlation with the central
memory cell, the death rate of the memory stem cell dST has a negative correlation.
This indicates the importance of the memory stem cell on the central cell popula-
tion. In addition, the transition rate for the central memory cell φC is negatively
correlated. This is an expected result as the higher the transition rate the more the
cells are leaving the central state. Lastly, the transition rate of the na¨ıve φN cell has
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a positive correlation with the central memory cell for only 30 days post treatment
initiation.
Transitional Memory cell
The transitional memory cell population has an equivalent result to the central cell,
where the na¨ıve and memory stem cell have an important effect on the reconstitution
of the transitional memory cell. This finding is evident as the sensitivity analysis
revealed that the rate λ and the memory stem cell proliferation rate pST both have
a positive correlation with the transitional memory cell population and the memory
stem cell death rate dST is negatively correlated. Moreover, as the previous memory
sub-populations, the transition rate of the transitional memory cell φT has a negative
correlation with the transitional memory cell population.
Effector Memory cell
The na¨ıve and transitional cells have a positive correlation with the effector memory
cell population where the na¨ıve cell production rate λ and stem cell transition rate
φST are strongly positively correlated with the effector memory population. In
addition, the effector memory proliferation pE rate has a very significant effect on
increasing the effector population count. The na¨ıve and central memory transition
rates, φN and φC , have positive correlations with the effector memory cell popula-
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tions for about 30 days post treatment. This is a likely result to be observed as
both types of cells do not have a long lifespan compared to the memory stem cell.
Lastly, the death rate of the effector dE and memory stem cell dST have a negative
correlation with the effector memory population.
Total na¨ıve an memory CD4 T-cell
From the observations drawn above, it is evident that the na¨ıve cell production rate
by the thymus λ plays an important role in increasing the total number of CD4
T-cell. Moreover, the transition rates for the na¨ıve φN and transitional memory
cells φT had a negative effect on the total CD4 T-cell count. The importance of the
stem cell population continues to be evident where its death rate dST has a negative
effect on the increase of he CD4 T-cell population. This concludes that both the
na¨ıve and memory stem cells both are important in the reconstitution of the total
CD4 T-cell count for patient 302.
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Parameters Baseline Non-modified T-cell SATN fit min-max
λ 8.764999372 13.6 16.1964 8.76499-16.1964
pN 0.001154028 0.189 0 0-0.189
pST 0.01097524 0.0914 0.0107 0.0107- 0.0914
pC 0.010877232 0.106 0 0-0.106
pT 0.021672918 0.00575 0.0356 0-0.0356
pE 0.033205325 0.274 0 0-0.0.274
φN 0.049752123 0.191 0.0517 0.0497-0.191
φST 0.465153919 0.459 0.1024 0.102-0.459
φC 0.110786451 0.325 0.0314 0.0314-0.325
φT 0.247755424 0.832 0.1341 0.1341-0.0.832
dN 0.010007563 0.000541 0.0483 0-0.0483
dST 0.011147981 0.00057 0.0083 0-0.01147
dC 0.003333333 0.106 0.686 0-0.686
dT 0.023187029 0.19 0.0015 0.00052-0.19
dE 0.288952838 0.796 0.1 0.1-0.796
Table 4.6: Illustrates the data fitting results for pat 302 and the LHs ranges. These
values are the rates per day−1.
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Figure 4.16: Correlation between the N and STM T-cell and the 15 parameters over
200 days for pat 302.
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Figure 4.17: Correlation between the CM and TM T-cell and the 15 parameters
over 200 days for pat 302.
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Figure 4.18: Correlation between the EM and total CD4 T-cell and the 15 parameters
over 200 days for pat 302.
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4.3.3 High Dose Cohort
The high dose cohort represents the three patients that received a single infusion
of autologous CCR5-modified (SB-728-T) 3.0 x 1010 cells. All of the baseline
measurements are measured seven days prior to the infusion of the CCR5 modified
T-cells. The three patients had a range of high to medium CD4 T-cell count at
baseline.
4.3.3.1 Patient 305
At baseline, this patient has a somewhat high count of 480 CD4 T-cell per µL.
Looking at table 4.7 we can note the following observations about each of the five
sub-population behaviors:
• The number of na¨ıve CD4 T-cells produced by the thymus λ slightly decreased.
• The proliferation rate for the na¨ıve cell pN has increased by one order of
magnitude.
• The proliferation rates for the memory stem pST , central memory pC , transi-
tional memory pT and effector memory cells pE decreased.
• The transition rates for all of the five subsets remained somewhat constant.
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• The death rate of the na¨ıve dN and memory stem cells pST decreased. However,
the death rate for the transitional memory pT and effector memory cells pE
remained constant.
As for the sensitivity analysis obtained over 200 days we observe the followings
from Figure 4.19, 4.20 and 4.21:
Na¨ıve Cell:
Similar to most of the patients, the na¨ıve cell production rate λ has a positive
correlation with the the na¨ıve cell population. Only the na¨ıve cell transition rate
φN has a negative correlation on the na¨ıve cell population count. The death rate dN
did not have any effect as it decreased significantly after the treatment initiation.
Memory Stem cell
The na¨ıve cell production rate λ continues to have a positive effect on the mem-
ory stem cell population count. The transition rate of the na¨ıve cell φN displays
a positive correlation with the memory stem count only for about 30 days post
treatment initiation. This is a result of the decrease in the transition rate for the
na¨ıve cell after the treatment as illustrated in the Table 4.7. The transition rate of
the memory stem cell φST is negatively correlated with its population.
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Central Memory Cell
Similarly to the memory stem cell, the na¨ıve cell production rate by the thymus
λ continues to exhibit a positive correlation with the central memory cell count.
Moreover, the transition rates of the na¨ıve φN and memory stem cells φST both have
a positive correlation with the central memory population for about 30 and 20 days
post treatment initiation respectively. The death and transition rates of the central
memory cell, dC and φC have a negative effect on the central memory cell popula-
tion count as these rates did not exhibit a decrease after the start of the clinical trial.
Transitional Memory cell
The central memory cell death rate dC and the transition rate of the transitional
memory cell φT both have a negative effect on the transitional memory cell popula-
tion count. In addition, the na¨ıve cell production rate from the thymus λ along with
the transition rate of the central memory cell φC are positively correlated with the
transitional memory cell population. This highlights the importance of the central
memory cell on the transitional cell population. The na¨ıve cell transition rate φN
has a positive correlation with the transitional memory cell population for about 50
days post treatment.
Effector Memory cell
155
The importance of the central memory cell continues to be observed in the effector
memory population, where the central memory death rate dC has a negative corre-
lation with the effector memory population and the central memory transition rate
φC has a positive correlation. In addition, the na¨ıve cell production rate λ has a
positive correlation. Similarly to the transitional cell population, the transition rate
for the na¨ıve φN , and transitional memory φT cells have a positive correlation for
about 50 days post treatment. The death rate of the effector memory cell dE has a
negative correlation as this value increased significantly after the initiation of the
experimental treatment.
Total na¨ıve an memory CD4 T-cell
The sensitivity analysis performed on the total CD4 T-cell count highlights the
importance of the central cell on the reconstitution of the CD4 T-cell, where the
death and transition rates of the central memory cells, dC and φC , both have a
negative correlation with the total CD4 T-cell count. The na¨ıve cell population as
well has some effect on the total CD4 T-cell count where the production rate λ has
a positive effect and the transition rate φN has a negative correlation with the CD4
T-cell count. These results illustrates that for patient 305, the central memory and
na¨ıve cells played an important role in the reconstitution of the total CD4 T-cell
count population.
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Parameters Baseline Non-modified T-cell SATN fit min-max
λ 10.51654578 8.96240 11.2318 8.96240-12.56407
pN 0.001136919 0.07369 0.0003 0-0.07369
pST 0.011035824 0.00396 0.1360 0.00396-0.1360
pC 0.010987609 0 0 0-0.010987609
pT 0.021796329 0.00141 0.0155 0-0.021796
pE 0.033211285 0.02939 0 0-0.033211285
φN 0.215314186 0.13602 0.0492 0.0492-0.215314
φST 0.464899665 0.48367 0.2358 0.2358-0.51269
φC 0.105961431 0.12000 0.0342 0.0342-0.1200
φT 0.233399786 0.32529 0.1082 0.182-0.3259
dN 0.011498048 0.00918 0.0511 0-0.0511
dST 0.011057469 0 0.0002 0-0.011057
dC 0.003333333 0.00148 0.0658 0.00082-0.0658
dT 0.023025425 0.01267 0.0073 0.0073-0.023025
dE 0.321528667 0.31500 0.1 0.1-0.32152
Table 4.7: Illustrates the data fitting results for pat 305 and the LHS ranges. These
values are the rates per day−1.
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Figure 4.19: Correlation between the N and STM T-cell and the 15 parameters over
200 days for pat 305.
158
Figure 4.20: Correlation between the CM and TM T-cell and the 15 parameters
over 200 days for pat 305.
159
Figure 4.21: Correlation between the EM and total CD4 T-cell and the 15 parameters
over 200 days for pat 305.
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4.3.3.2 Patient 303
At baseline, this patient had a somewhat medium level of CD4 T-cell count of
330 cells per µL. Looking at Table 4.8 we can note the following observations about
each of the five sub-population behaviors:
• The number of na¨ıve CD4 T-cells produced by the thymus λ slightly increased.
• The proliferation rates for the na¨ıve pN and transitional memory cell pT
increased by one order of magnitude.
• The proliferation rate for the central memory cell pC decreased by one order
of magnitude.
• The transition rate for the na¨ıve cell φN increased by one order of magnitude.
• The transition rate for both the memory stem φST and central memory cells
phiC decreased.
• The death rates of the na¨ıve dN , transitional memory dT and memory stem
cell dST decreased.
• The death rate of the central memory cell dC increased by one order of
magnitude.
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As for the sensitivity analysis obtained over 200 days we observe the followings
from Figures 4.22, 4.23 and 4.24:
Na¨ıve Cell:
Similar to patient 303, the na¨ıve cell production rate λ has a positive correlation
with the na¨ıve dell population and the na¨ıve transition rate φN has a negative
correlation. The death rate dN did not have any effect as it decreased significantly
after the treatment initiation.
Memory Stem cell
The memory stem cell proliferation rate PST has a strong positive correlation with
the memory stem cell population. However, unlike the previous patients, the thymic
production rate of na¨ıve cell λ did not have a strong positive correlation on the
memory stem cell population. This could be explained by the fact that the na¨ıve cell
death rate dN and production rate λ did not have a significant change from baseline.
The central memory death rate dc has a weak positive effect on the memory stem
cell population and the transition rate of the memory stem cell φST has a negative
correlation.
Central Memory Cell
The importance of the memory stem is still noticeable in the central memory popu-
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lation where its proliferation rate pST has a very strong positive correlation with
the central memory cell count. The na¨ıve cell birth rate λ continues to exhibit a
weak positive correlation. the central memory cell death and transition rates, dC
and φC both are negatively correlated with the central cell population. This could
be a result of the increase in the central memory death rate dC after the initiation
of the treatment as shown in Table 4.8.
Transitional Memory cell
The memory stem cell continue to maintain its importance in the transitional
memory population, where its proliferation rate pST is strongly positively corre-
lated with the transitional memory cell population. In addition, while the central
memory cell death rate dC has a negative correlation with the transitional memory
cell populations, transition rate φC is positively correlated. This highlights the
importance of both the memory stem and central CD4 T-cells on the reconstitu-
tion of the effector memory cell. The na¨ıve cell production rate by the thymus
λ does not exhibit a very strong positive effect. Lastly, the transition rate of the
transitional cell φT has a negative correlation with the transitional memory cell count.
Effector Memory cell
While the effector memory cells have similar results to the transitional cells when it
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comes to the importance of the central and memory stem cell, the transition rate of
the transitional memory cell φT is positively correlated with the effector memory
cell population. This is an expected result as the more cells are transitioning from
the transitional memory to effector memory state, the effector memory population
is exhibiting an increase in its count.
Total na¨ıve an memory CD4 T-cell
It is expected to observe that the memory stem and central cell will play an impor-
tant role in the reconstitution of the total CD4 T-cell count. The memory stem
cell proliferation rate pST and the na¨ıve cell production λ both have a positive
correlation on the total memory CD4 T-cell count. This indicates as we increase
these model parameters, the total CD4 T-cell population will increase. In addition,
the death rate of the central memory cell dC and the transition rate of the memory
stem cell φST are both negatively correlated with the total CD4 T-cell count. These
results indicates that the memory stem cell population have a very important role
in increasing or maintaining a high level of CD4 T-cell count in patient 303.
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Parameters Baseline Non-modified T-cell SATN fit min-max
λ 8.445704953 10.75440 10.2921 8.44570-32.5
pN 0.001153966 0.01191 0.0078 0-0.01191
pST 0.011042777 0.01122 0.0425 0.01104-0.991
pC 0.010995681 0.00737 0 0-0.010995
pT 0.021578612 0.27041 0.0007 0.00
pE 0.033205325 0.02316 0 0-0.03320
φN 0.082314245 0.10208 0.0986 0.0823-0.304
φST 0.464899661 0.11758 0.1419 0.11758-0.628
φC 0.107979023 0.09603 0.0196 0.0196-0.096
φT 0.247968152 0.24667 0.0575 0.0575-0.397
dN 0.009633584 0.00559 0.0093 0-0.0093
dST 0.011193147 0.00538 0.0006 0-0.01119314
dC 0.003333333 0.44393 0.0804 0.00333-0.44393
dT 0.023148944 0.01795 0.0431 0-0.0431
dE 0.515148304 0.49886 0.1 0.1-0.705
Table 4.8: Illustrates the data fitting results for pat 303 and the LHS ranges. These
values are the rates per day−1.
165
Figure 4.22: Correlation between the N and STM T-cell subsets and the 15 parame-
ters over 200 days for pat 303.
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Figure 4.23: Correlation between the CM and TM T-cell subsets and the 15
parameters over 200 days for pat 303.
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Figure 4.24: Correlation between the EM and total CD4 T-cell and the 15 parameters
over 200 days for pat 303.
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4.3.3.3 Patient 304
At baseline, this patient had a somewhat medium level of CD4 T-cell count of
306 cells per µL. Looking at Table 4.9 we can note the following observations about
each of the five sub-population behaviors:
• The number of na¨ıve CD4 T-cells produced by the thymus λ increased.
• The proliferation rates for the na¨ıve pN and memory stem cell pST increased
by at least one order of magnitude.
• The proliferation rates for the central memory pC , transitional memory pT
and effector memory cells pE decreased.
• The transition rate for all the four subsets of cell increased.
• The death rate of the effector memory dE and central memory cells dC
increased.
• The death rate for the na¨ıve dN , transitional memory dT and memory stem
cell dST decreased.
As for the sensitivity analysis obtained over 200 days we observe the following
from Figures 4.25, 4.26 and 4.27:
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na¨ıve Cell:
While the na¨ıve cell production rate λ is positively correlated with the na¨ıve cell
count, the transition rate of the na¨ıve cell φN has a negative correlation. The same
results were observed in both patients 305 and 303 from the same cohort. The death
rate dN did not have any effect as it decreased significantly after the treatment
initiation.
Memory Stem cell
The na¨ıve cell production rate λ has a strong positive correlation with memory stem
cell population. As the transition rate of the memory stem φST cell had an increase
after the introduction of the down modulated CCR5 CD4 T-cells, it showed to have
a negative correlation with the memory stem population. The transition rates of
the na¨ıve cell φN has a positive correlation with the memory stem cell population
for about 30 days post treatment initiation.
Central Memory Cell
Similar to the na¨ıve and memory stem cell, the na¨ıve cell production rate λ has a
positive correlation with the central memory cell population. While the transition
rate of the central memory cell φC has a negative correlation with the central
memory cell, the transition rate of the memory stem φST is positively correlated for
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about 40 days post treatment.
Transitional Memory cell
As The transitional memory cell has a positive correlation with the na¨ıve cell pro-
duction rate λ, the transition rates for both the central memory and na¨ıve cells,
φC and φN , both have a significant positive correlation for the first 40 days. The
death rate of the transitional cell dT along with the transition rate φT are negatively
correlated with the transitional memory cell count.
Effector Memory cell
The importance of the na¨ıve and transitional cell are evident in the effector cell
population, as the na¨ıve production rate by the thymus λ and the transitional cell
transition rate φT both have a strong positive correlation with the effector memory
population. Both the death rate for the transitional and effector memory cells, dE
and dT , are negatively correlated with the effector memory cell population.
Total na¨ıve an memory CD4 T-cell
In the sensitivity analysis results obtained for the total number of CD4 T-cell, the
importance of the na¨ıve cell population is evident where the na¨ıve production rate λ
is the only parameter that has a positive effect on the total T-cell count. In addition,
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the transition rates for both the na¨ıve and central memory cells, φN and φC , both
have a negative effect on the total CD4 T-cell count. The sensitivity analysis results
indicates that for patient 304 the na¨ıve and central memory cells play an important
role in the reconstituting the total CD4 T-cell count as seen in both patients 303
and 305.
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Parameters Baseline Non-modified T-cell SATN fit min-max
λ 9.086416508 14.34899 8.3187 8.3187-48.2
pN 0.001154028 0.22369 0.0227 0-0.22369
pST 0.01097524 0.67151 0.1237 0-0.67151
pC 0.010877232 0 0 0-0.010877
pT 0.021672918 0 0 0-0.02167
pE 0.033205325 0.0232 0 0-0.0333205
φN 0.049752123 0.26594 0.1135 0.04975-0.304
φST 0.465153919 0.61831 0.2234 0.2234-0.61831
φC 0.110786451 0.26555 0.0533 0.0533-0.2655
φT 0.247755424 0.39893 0.0466 0.0466-0.491
dN 0.010007563 0 0.0092 0-0.010007563
dST 0.011147981 0 0.0004 0-0.0111479
dC 0.003333333 0.44 0.0467 0-0.44
dT 0.023187029 0 0.0534 0-0.0534
dE 0.288952838 0.99672 0.1 0.1-0.99672
Table 4.9: Illustrates the data fitting results for pat 304 and the LHs ranges. These
values are the rates per day−1.
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Figure 4.25: Correlation between the N and STM T-cell and the 15 parameters over
200 days for pat 304.
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Figure 4.26: Correlation between the CM and TM T-cell and the 15 parameters
over 200 days for pat 304.
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Figure 4.27: Correlation between the EM and total memory CD4 T-cell and the 15
parameters over 200 days for pat 304.
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4.3.4 Brief Summary
In this section we will summarize the results that we have presented in this
chapter. First we will summarize the interesting changes in some model parameters
by comparing the fits obtained at baseline and after the injection of the CCR5-
down-modulated memory CD4 T-cells, we have seen that the death rate of the
memory stem cells dST and the na¨ıve cell dN have always decreased in magnitude
and for some patients it was 0. This finding further indicates that the injection
of the CCR5-down-modulated memory CC4 T-cells has succeeded in increasing
the lifespan of the na¨ıve and memory stem cell subset population in all the three
HIV positive cohorts. In addition, patients who are categorized under the imm-
nunodiscordant group where the CD4 T-cell count is < 350 [31] and received a
low dose of the CCR5-down-modulated CD4 T-cells injection had a decrease or
no change in the naive cell production rate λ which was seen in patients 103 and
104. However, when immunodiscordant patients(203,304,303) received a higher
dose of the injection double or triple of the low dose cohorts, they experienced an
increase in the naive cell production λ as seen in patients 203, 304 and 303. As
for the immunoconcordant individuals, patients with CD4 T-cell count > 400 [31],
no matter what the injection dose was they experience an increase in the naive
cell production λ. The central memory cell death rate dC have increased in all
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immunodiscordant patients(103,104,203,303,304) along with two of the low and
medium dose cohorts that are immunoconcordant which had < 500 cells/µL. When
an immunoconcordant medium dose cohort patient had > 500 cell/µL and a high
dose immunoconcordant patients(305), the death rate of the central memory cells
dC decreased. The death rate of the transitional memory cell dT have increased in
low dose immunodiscordant individuals along with the immunoconcordant medium
dose cohort(201,302). However, it decreased in immunodiscordant medium and
high dose cohort(203,303,304) and high dose immunoconcordant individual (305).
The effector memory cell death rate dE, decreased in immunoconcordant high dose
cohort(305) and in immunodiscordant high and medium dose cohort(303,304,203).
dE increased in all low dose cohort(102,103,104) and immunoconcordant medium
dose cohort(201,302). As for the memoy stem cell proliferation rates pST , immun-
odiscordant low dose cohort(103,104) and immunoconcordant high dose cohort(305)
experienced a decrease. It is important to note that patient 305 is the only patient
who experienced a decrease in the total CD4 T-cell count 3 years after the treatment.
The immunodiscordant medium and high dose cohort (203,303,304) along with the
immunoconcordant low and medium dose cohort(102,201,302) have expereinced an
increase in the memory stem cell proliferation 3 years after the treatment initiation.
As for the uncertainty and sensitivity analysis results we obtained the following
result summary which can be summarized in the Tables 4.10, 4.11, 4.12,4.13 and
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4.14 below:
• The na¨ıve cell production rate λ had a positive correlation with all the na¨ıve
and memory CD4 T-cells in all immunoconcordant individuals no matter what
the injected dose of the CCR5-down-modulated memory CD4 T-cells was along
with the high and medium dose immunodiscordant individuals(203,303,304).
However, the immunodiscordant low dose individuals did not experience that
significant importance of the na¨ıve cell production rate λ on the na¨ıve and
memory CD4 T-cell populations (patients 103 and 104).
• The proliferation rate of the central memory cell pC had a positive correlation
on the CD4 T-cell sub-populations when immunodiscordant low dose patients
did not have an increase in their na¨ıve production rate after the treatment as
for pat. 104. In addition, immunoconcordant low dose pat 102 transitional
memory CD4 T-cell population had a positive correlation with the central
memory cell population. This further indicates that the central memory
cell proliferation rate was more important in low dose immunodiscordant
individuals that did not experience an increase in the na¨ıve cell production
rate λ.
• The proliferation rates for memory stem cell pST and na¨ıve cells pN had a pos-
itive correlation withe the CD4 T-cell subsets for low dose immunodsicordant
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and immunoconcordant individuals(102,103). Moreover, memory stem cell
proliferation rate pST had a positive correlation with the CD4 T-cell subsets
of high dose immunodiscordant individual 303. As for the immunodiscordant
low dose patient 104 where the na¨ıve and memory stem cell proliferation rates
along with the na¨ıve cell production rate λ did not play an important role,
the proliferation of the central memory cell pC had a positive correlation with
the CD4 T-cell sub-populations.
• The central memory death rate dC was negatively correlated with the CD4
T-cell population of the low dose immudiscordant and immunoconcordant
individuals(102,103,104). In addition we observed the same effect in all
immunoconcordant individuals regardless of the injected dose of CCR5-down-
modulated memory CD4 T-cell except for medium dose patient 302.
• The death rate of the memory stem cell population had a negative correla-
tion on the CD4 T-cell subsets only in the medium dose immunoconcordant
individual 302.
• The transition rate of the central memory cell φC had a negative correlation
on the total CD4 T-cell count and a positive correlation with the effector
and transitional memory CD4 T-cells in all high dose cohorts despite their
CD4 T-cell levels. In addition the same was observed in immunodisocrdant
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medium dose cohort patient 203. The na¨ıve cell transition rate φN had a
negative correlation with the total CD4 T-cell count in medium and low
dose immunodiscordant individuals and one immunoconcordant high dose
individual that experienced a decrease in the total CD4 T-cell count after
three years as illustrated in table 1.1 in Chapter 1.
Now comparing the patients according to the injected CCR5-down-modulated
memory CD4 T-cells we can draw the following conclusions:
• For the low dose cohort, when the patient had a fairly high CD4 T-cell count
at baseline, at the end of the treatment the patient experienced a small amount
of increase in the Total CD4 T-cell count. The na¨ıve and memory stem cells
played an important role in this increase. However, when the patient had a
fairly low amount of CD4 T-cell at baseline, after the reinstatement the count
of CD4 T-cell almost doubled. In these patients we observed two important
points. If the patients had an increase in the number of na¨ıve cell after the
treatment, the na¨ıve cells were the only population that played an important
role in this increase. But when the number of na¨ıve did not have any significant
change, the central memory cell is the population that played an important
role in the increase of the T-cell count.
• For the medium dose cohort, when the patient had a low CD4 T-cell count
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at baseline, the na¨ıve and central memory cell played an important role in
increasing the total CD4 T-cell count by more than double the count. When
having a somewhat high baseline count(400-500) at baseline, the patients
experience an increase by a 1.5 factor where the memory stem cell and na¨ıve
cells played an important role in the CD4 T-cell count increase. However,
it is important to note that when the number of na¨ıve cell produced by the
thymus did not have a significant increase from baseline value, the memory
stem played an important role. But when the number of na¨ıve cell produced
by the thymus had a significant increase the na¨ıve and central memory cells
played an important role in the reconstitution of the CD4 T-cell count as the
low dose cohort. These patients experienced a higher increase in their CD4
T-cell count compared to the other two cohorts.
• For the high dose cohort, the patient who experienced the most significant
increase in the CD4 T-cell was due to an increase in the na¨ıve cell production
rate λ and a decrease in the memory central cell population. When the na¨ıve
cell production did not have any increase, the memory stem cell was the
population that contributed to the increase in the total CD4 T-cell. However,
when one of the patients had a decrease in the production rate of the na¨ıve
cell, the total number of CD4 T-cell at the end the three years decreased
significantly. This points out the importance of the na¨ıve cell which was
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evident in all the three cohorts. This last result supports previous finding
where researchers found that the CD4 T-cells are highly resistant to the HIV
infection [53].
Parameters N103 N104 S103 S104 C103 C104 T103 T104 E103 E104 TOT103 TOT104
λ + + +
pN + + + + + +
pST + + + + + + +
pC + + + + + +
pT + +
pE +
φN - - -
φST - -
φC - - + -
φT - - +
dC - - - - - - - -
dE + - - +
Table 4.10: Correlation between the model parameters and the CD4 T-cell popu-
lation. Where + = positive correlation and - = negative correlation for low dose
immuodiscordant patients 103 and 104.
183
Parameters N304 N303 S304 S303 C304 C303 T304 T303 E304 E303 TOT304 TOT303
λ + + + + + + + + + + + +
pST + + + + +
φN - - -
φST - - -
φC - + + -
φT - - +
dC + - - - -
dT - -
dE -
Table 4.11: Correlation between the model parameters and the CD4 T-cell popula-
tion. Where + = positive correlation and - = negative correlation for immunodis-
cordant high dose patients(303,304).
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Parameters N102 S102 C102 T102 E102 TOT102 N305 S305 C305 T305 E305 TOT305
λ + + + + + + + + + + + +
pN + + + + + +
pST + + + + + +
pC +
φN - - - -
φST - -
φC - - - - + + -
φT - - -
dC - - - - - - - -
dE - -
Table 4.12: Correlation between the model parameters and the CD4 T-cell population.
Where + = positive correlation and - = negative correlation for immunoconcordant
Low dose(102) and high dose patient (305).
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Parameters N201 N302 S201 S302 C201 C302 T201 T302 E201 E302 TOT201 TOT302
λ + + + + + + + + + + + +
pE +
φN - - + - -
φST - - + +
φC - - + +
φT - - + -
dST - - - - -
dC - - - -
dE -
Table 4.13: Correlation between the 15 model parameters and the 5 T-cell sub-
sets along with the total number of T-cell for immunoconcordant medium dose
patients(201,302).
Parameters N203 S203 C203 T203 E203 TOT203
λ + + + + + +
φN - -
φST -
φC - -
φT - -
Table 4.14: correlation between the 15 model parameters and the 5 T-cell subsets
along with the total number of T-cell for immunoconcordant medium dose patient
203
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5 Variability in CD4 T-cells population
5.1 Introduction
In addition to parameter uncertainty, model variability is an important matter
to address when modeling in host biological phenomenon. As our main focus in
this work is the dynamics of the memory and na¨ıve CD4 T-cells, it is important to
address the natural variability that arises from the stochastic nature of the T-cells
in the body in each of the nine patients.
5.2 Stochastic Model
In the previous chapter, we presented our stochastic model that we derived
using the Gillespie’s algorithm. In this section we will compare the results of the
steady state obtained by both the deterministic model Eq’s 2.1 and the stochastic
model Eq’s 2.4. Using a stochastic model will allow us to estimate the natural
variability in the na¨ıve and memory CD4 T-cell model that could not be captured in
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a deterministic setting. To compare the ODE and stochastic model, we will simulate
the five T-cell subsets along with the total number of CD4 T-cell in a single µL
of plasma. We will be using the parameter estimates obtained from the baseline
fit in Matlab (section 3.3.1), Stan fit (3.3.2) and the best fit from Monolix. This
methodology will allow us to further investigate to what extent each of the fit can
capture the data measurements by the fluctuations that arise from the stochastic
model. Later, we will calculate the steady state value of the five cell subsets using
both the ODE(Eq’s 2,1) and MCMC(Eq’s 2.4), along with the standard error of
the mean. The standard error of the mean, SEM, will be obtained by dividing the
standard error by the square root of the number of runs performed in the stochastic
model. The results for each of the three cohorts is represented separately.
In Tables 5.1, 5.2 and 5.3 it was shown that for each of the parameter estimates,
the steady state values obtained from both the ODE and MCMC were similar with
a small SEM.
Low Dose Cohort
In Table 5.1, it was shown that for the three patients, the na¨ıve cell steady state
after the initiation of the treatment was the same as the steady state achieved at
baseline. This indicates that the na¨ıve cell did not increase in count in the low dose
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cohort. As for the memory stem cell, patients 103 and 102 did not have an increase
in the stem cell count. However, patient 104 showed a significant increase where
the data value was in 1 standard deviation with the steady state obtained from the
parameter estimation in Monolix. The central memory cell population estimated
count by the ODE and stochastic model using the Monolix parameter fit was in
close proximity to the real data value at 36 months post treatment for all the three
patients which indicated an increase from the baseline value. Patient 104 and 103
steady state value was in close proximity to the steady state given by the baseline fit.
This indicates that this population of cell did not exhibit any significance increase.
However, patient 102 steady state value was closer to the parameter fit obtained
from Monolix. For this patient the transitional memory cell steady state increased
from the baseline value. In patient 104, the effector memory data measurement at
36 months, was closer in value to the steady state obtained by the MCMC model
using Stan fitting results which resulted in a decrease in the population from the
baseline value. Patient 103 and 102 data measurements at 1080 days was closer to
the steady state calculated using the MCMC from the fitting obtained in Monolix.
As for the total number of CD4 T-cell, all of the patients had an increase from the
baseline value where the Monolix estimation using the MCMC model was closer to
the data measurement at 36 months.
From Table 5.1, we can conclude that the patient that had the most significant
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increase in the total number of CD4 T-cell from baseline is the one that had an
increase in the memory stem cell population as a result of the experimental treatment.
This was evident in patient 104 where the baseline for the total number of T-cell
was 261 cell per µL that increased to 455 cell per µL three years post-treatment.
This again highlights the importance of the memory stem cell population.
Figure 5.1 shows that most of the CD4 T-cell population for the three patients were
in at least 1 standard deviation from the steady state calculated from the MCMC
model using the Monolix data fitting values. This indicates that our stochastic
model was able to capture the dynamics of the CD4 T-cell. In addition, a realization
of the stochastic model (Figure 5.2) using the Monolix fit (LN) shows how the
fluctuations of our model was able to capture the data measurements for all the
three patients. However, the Total CD4 T-cell data measurement was not captured,
this is because we defined the total CD4 T-cell by simply adding the five T-cell
subsets differently measured unlike how our collaborator measured those cells.
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Na¨ıve Memory stem Central memory Transitional memory Effector memory Total CD4 T-cell
102 Baseline ODE 40.77 18.8 86.23 34.45 129.7 310.8
MCMC 40.6417 18.63455 86.1430 35.7022 130.5261 311.6530
±SEM 0.3686 0.2396 0.5207 0.3406 0.6820 0.9460
102-MON ODE 79.98 80.39 219.8 54.34 89.3 523.6
MCMC 80.7210 80.1730 216.8873 53.5757 88.9752 520.3506
±SEM 0.5734 0.60255 1.1515 0.4781 0.6274 1.7880
102 STAN ODE 70.25 56.44 133 28.68 53.42 341.4
MCMC 69.8927 55.9081 134.6426 29.4694 54.7132 344.6428
±SEM 0.5158 0.5657 0.9534 0.3652 0.6331 1.5329
Val. at 36 months 51.6 28.4 197.6 48.2 102.3 518
104 Baseline ODE 27.98 15.89 71.89 30.53 73.68 220.2
MCMC 27.4404 15.5202 68.8210 30.3845 73.022 215.1937
±SEM 0.30686 0.2308 0.5779 0.3419 0.5881 1.1155
104 MON ODE 67.8813 119.9 104.7 22.79 15.38 331.2
MCMC 67.8813 116.8126 103.2355 22.8445 15.3936 326.2180
±SEM 0.4862 0.8149 0.7338 0.2989 0.2561 1.51126
104 STAN ODE 58.11 77.01 89.24 18.54 29.32 270.3
MCMC 57.8486 77.4645 88.9932 17.9478 28.9492 271.2814
±SEM 0.4869 0.6107 06717 0.2717 0.3962 1.2750
Val. at 36 months 76.7 119.3 124.6 30.6 27.5 455
103 Baseline ODE 37.8 12.64 58 24.86 14.35 147.6
MCMC 37.3896 12.7074 56.3290 24.1237 14.1110 144.6629
±SEM 0.3434 0.1981 0.4422 0.2848 02194 0.7199
103-MON ODE 27.51 12.92 98.36 35.58 65.8 240.10
MCMC 28.4891 13.2551 101.6508 36.9183 68.2782 248.5790
±SEM 0.3206 0.2152 0.7425 0.4233 0.7867 1.2938
103-STAN ODE 26.63 17.98 64.52 20.96 39.61 169.7
MCMC 26.3436 18.1230 63.8209 19.7328 38.0755 166.0909
±SEM 0.3111 0.3786 0.7337 0.3553 0.4916 1.2115
Val. at 36 months 38 9.6 81.9 28.6 104 315
Table 5.1: Low dose cohort’s steady state for each of the CD4 T-cell subsets using
the ODE and stochastic models. 300 runs are used in the MCMC model.
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Figure 5.1: Error bar low dose cohort of the steady with experimental data points.
192
Figure 5.2: 10 stochastic realizations for low dose cohort.
193
Figure 5.3: 10 stochastic realizations for low dose cohort.
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Medium Dose Cohort
Looking at Table 5.2 and Figures 5.3 and 5.4 we observe the observation below :
In patient 203, the data measurements for the six population of cells at 36 months
post-treatment was in close proximity to the steady state obtained in the MCMC
by using data estimates from Monolix. The memory stem cell along with the na¨ıve
and central memory cells showed a significant increase from baseline. The total
number of CD4 T-cell have increased form 294 to 617 cells per µL. The importance
of the memory stem, central memory and na¨ıve cells play an essential role in the
reconstitution of the CD4 cell count in this patient. It is important to note that
the increase in the total CD4 T-cell count was one time an a half greater than the
patients from low dose with similar baseline count for the total CD4 T-cell.
As for patient 302, the data measurements for the memory stem, transitional memory
and effector memory were in at least one to two standard deviation from the steady
state calculated by the MCMC model as shown in Figure 3.3. However, the MCMC
model for patient 201, showed a small variability between the estimated steady state
and the data measurements after three years, indicating that the MCMC model
does a fairly good job in describing the dynamics of the CD4 T-cell for patient
201. All of the three patients had an increase in their total CD4 T-cell populations.
Figure 5.4 shows how the stochastic model suing the Monolix parameter estimates
was able to capture all the data measurements. This further indicates the validity of
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our model and the importance of using stochastic models to capture variably within
and between individuals.
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Na¨ıve Memory stem Central memory Transitional memory Effector memory Total CD4 T-cell
203 Baseline ODE 52.42 18.44 85.43 35.26 25.18 216.7
MCMC 52.9382 18.3199 85.2483 35.0252 25.4318 216.9625
±SEM 5.4730 0.3026 0.6717 0.4101 0.36628 1.0479
203-MON ODE 70.66 69.55 162.4 36.95 26.68 366.2
MCMC 71.6534 70.8923 165.0647 37.2156 26.9858 371.8109
±SEM 0.7155 0.7410 1.0988 0.4539 0.37901 1.8823
203 STAN ODE 68.14 34.74 124.7 36.01 67.91 329.5
MCMC 68.7948 36.2339 128.4525 36.2193 68.2193 337.7407
±SEM 0.61518 0.5812 1.13985 0.50911 0.6505 1.75928
Val. at 36 months 108.7 70.7 202.5 46.7 34.2 617
302 Baseline ODE 148.7 15.79 69.03 29.92 27.94 291.4
MCMC 148.2785 16.0114 68.4546 30.0212 28.16658 290.9211
±SEM 0.8061 0.29998 0.608 0.4186 0.4044 1.15965
302 MON ODE 70.55 69.47 162.3 36.93 26.65 365.9
MCMC 70.535 69.4977 158.6232 36.6385 26.1904 361.4967
±SEM 0.7976 0.7311 1.11157 0.45113 0.36911 1.8087
302 STAN ODE 162 81.35 11.62 3.353 4.506 262.9
MCMC 161.317 81.1099 11.4666 3.0770 4.6135 262.4085
±SEM 0.4869 0.6107 0.6717 0.2717 0.3962 1.2750
Val. at 36 months 236 42 98.8 39.9 51.7 606
201 Baseline ODE 127.5 20.32 96.46 39.06 22.53 305.8
MCMC 127.5483 20.4968 97.3861 39.3882 23.032 307.8527
±SEM 0.81034 0.3337 0.7566 0.4511 0.3394 1.3010
201-MON ODE 210 297.9 313.11 85.87 36.4 943.3
MCMC 209.5010 299.0.79 311.4175 85.0449 36.2554 941.2943
±SEM 0.9630 1.429 1.5924 0.6943 0.451135 2.630
201-STAN ODE 140.5 213.4 210.1 61.24 26.25 651.5
MCMC 139.5236 211.5900 207.9940 61.9867 26.2680 647.2886
±SEM 0.7608 1.1228 1.2247 0.5133 0.4030 2.3122
Val. at 36 months 176.7 143.8 248.9 54.8 27.2 848
Table 5.2: Medium dose cohort’s steady state for each of the CD4 T-cell subsets
using the ODE and stochastic models. 300 runs are used in the MCMC model.
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Figure 5.4: Error bar for medium dose cohort of the steady state of the MCMC
model
198
Figure 5.5: 10 stochastic realization for the medium dose cohort.
199
Figure 5.6: 10 stochastic realization for the medium dose cohort.
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High Dose Cohort
Looking at Table 5.3 and Figures 5.5 and 5.6 we observe the observations below.
In patient 305, the data measurements for the six population of cells at 36 months
post-treatment was in close proximity to the steady state obtained in the MCMC
by using data estimates from Monolix. The number of central memory, na¨ıve and
transitional memory cells decreased as shown in Figure 5.5 which led to a decrease
in the total number of CD4 T-cell. The MCMC model was able to capture the CD4
T-cell dynamic for this patient. This further validates the goodness of our model.
Patient 303 CD4 T-cell population confirmed the validity of our MCMC model
where most of the data measurement where within the standard deviation bar at
the steady state as shown in Figure 5.5. This patient did not show a significant
increase in all of the memory cell count which led to having a very small increase in
the total number of CD4 T-cell.
As for patient 304, the data measurements for all of the CD4 T-cell subsets were
in at least one to two standard deviation from the steady state calculated by the
MCMC model as shown in Figure 5.5. Similarly, as this patient did not experience
an increase in their memory stem and transitional memory, it did not result with an
increase in the total CD4 T-cell count. Nevertheless, this patient was not followed
for a period of three years hence we are not able to firmly understand the effect of the
clinical trial on their CD4 T-cell count. Figure 5.6 further shows that fluctuations
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from our stochastic model are able to capture the data measurements. However, as
the previous patients, the CD4 T-cell memory is not well captured as the definition
between the model and the experimental data of the total CD4 T-cell varies. this
indicates that our model underestimates the experimental data measurements for
the the total number of CD4 T-cell.
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Na¨ıve Memory stem Central memory Transitional memory Effector memory Total CD4 T-cell
304 Baseline ODE 50.41 18.44 83.86 36.23 24.25 213.2
MCMC 50.8774 18.7154 83.9669 36.3757 23.8453 213.7767
±SEM 0.03258 0.0217 0.0511 0.0315 0.258 0.0804
304-MON ODE 104.3 119.7 104.5 69.63 28.23 425.8
MCMC 106.5673 119.3142 104.5175 70.1099 27.9563 428.4660
±SEM 0.92936 1.083 0.8993 0.67025 0.4052 2.1189
304 STAN ODE 97.43 97.51 179.7 122.1 43.98 540.4
MCMC 96.2795 99.3641 179.0027 122.8336 44.1077 541.5196
±SEM 0.6986 1.190 1.13987 0.98446 0.5126 2.69107
Val. at 36 months 114.5 NaN 203.8 84.4 41.8 757
303 Baseline ODE 92.75 16.33 73.81 31.32 15.86 230.1
MCMC 92.3040 1.7585 75.2461 31.2035 16.0882 231.6068
±SEM 0.0452 0.0213 0.0477 0.0261 0.0187 0.0806
303 MON ODE 108.6 96.56 21.14 30.15 14.91 271.4
MCMC 109.2415 94.0503 21.7402 31.2544 15.3950 271.6823
±SEM 0.05176 0.06091 0.0239 0.0513 0.0274 0.1034
303 STAN ODE 100.1 86.06 122.1 23.88 13.74 345.5
MCMC 99.7113 84.3362 121.2785 22.3015 13.3420 341.0045
±SEM 0.0547 0.0548 0.0628 0.0251 0.0176 0.1091
Val. at 36 months 129.2 64.4 147.7 30.4 19.8 525
305 Baseline ODE 131.4 19.45 88.91 39.03 30.51 309.3
MCMC 132.0991 18.9786 88.2353 38.5513 30.2379 308.0919
±SEM 0.0509 0.0221 0.0471 0.0301 0.0289 0.0871
305-MON ODE 95.02 26.85 107.21 38.14 42.07 309.2
MCMC 95.9471 27.1896 107.2144 38.1235 42.2247 310.6977
±SEM 0.0559 0.0278 0.0528 0.0322 0.0354 0.1074
305-STAN ODE 112.2 39.03 91.95 30.04 32.49 305.7
MCMC 113.1999 39.5414 91.0155 29.7937 32.0592 305.5785
±SEM 0.0481 0.0434 0.0592 0.0271 0.0269 0.1035
Val. at 36 months 65.5 27.9 88.4 35.9 54.1 340
Table 5.3: High dose cohort’s steady state for each of the CD4 T-cell subsets using
the ODE and stochastic models. 300 runs are used in the MCMC model.
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Figure 5.7: Error bar graph for high dose cohort of the steady state of the MCMC
model. 204
Figure 5.8: 10 stochastic realization for the High dose cohort.
205
Figure 5.9: 10 stochastic realization for the High dose cohort.
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6 Conclusion and Future Directions
In mathematical biology, the main purpose of mathematical models is to gather
the proper information and analysis with the aim of informing medical researchers
and health care professionals about the efficacy of a drug.
Highly active antiretroviral therapy (HAART) have been used to suppress and
prevent the HIV replication with the aim of delaying and slowing down the disease
progression. However one of the main drawbacks and challenges of the HAART are
the toxicity and the emergence of the drug-resistant strains of the virus as HAART
is a life long therapy. Due to these facts and the nature of this virus, researchers
have switched their focus from making a vaccine to using immunotherapy. HIV
immunotherapy is used to boost and utilize the body’s own immune system in order
to suppress the HIV progression. The success of this approach remains unclear to
the scientific community.
This thesis focused on investigating the effect of the insertion of the CCR5-down-
modulated memory CD4 T-cell on reconstituting the immune CD4 T-cell population
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in nine different chronically infected HIV patients. The key challenge in analyzing
the effect of such study, is to build a sufficiently exact model that describes the
immune system dynamics and estimating important biological parameters from the
experimental data.
In Chapter 2, we have introduced a deterministic model using an ODE set of
equations to describe the inward and outward flow within and between the 5 CD4
T-cell sub-populations. Later, a stochastic model was developed using the Gillespie
algorithm.
In chapter 3, we have showed several fitting routines used to estimate the model
parameters. The best fit model was chosen based on some statistical criterion such
as the AIC and the standard error. Plots for the individual fits and the observed vs
prediction graphs were used to asses the goodness of the fits. Parameter identifiablity
and over-fitting issues were addressed. It is important to mention that some of the
proliferation rates were 0, indicating that the number of CD4T-cell have increased
to a maximum capacity that proliferation cannot take place. This further indicates
the positive effect of the treatment. In addition, we observed that the death rates
for the stem cell was 0 for a lot of patients, indicating that the stem memory are
having an increase in their lifespan. This further points out the importance of such
cell populations.
In Chapter 4, in order to highlight the change in the fifteen biological parameters
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( birth, death, proliferation and transition), after the initiation of the treatment
we compared the estimation of the best fitted model to the baseline. We realized
that the na¨ıve cell and memory stem lifespan have increased in all the nine patients.
In addition, the na¨ıve cell production rate λ increased in all immunoconcordant
patients despite the infused dose but increase only in immundiscordant patients
that received a medium and high dose of CCR5-down-modulated memory CD4
T-cells. However, λ decreased for all low dose immunodicordant individuals. Further,
using the uncertainty sensitivity analysis techniques, we studied the importance of
these model parameters to each of the 5 sub-population and the total CD4 T-cell
populations. From these results we are able to conclude that the most important
cell populations were the na¨ıve, memory stem and central memory cells. This was
evident by observing the positive effect of the thymic production rate λ, memory
stem cell and central memory cell proliferation rates pST and pC along with the
negative correlation with the na¨ıve, memory stem and central memory death rates
dN , dST and dC . In addition, the medium dose cohort experienced on average a
higher significant increase in the total number of CD4 T-cell. In a nutshell, from
this experiment we were able to show that not just the na¨ıve cell are important
in reconstitution the CD4 T-cell memory as proven in previous studies, but when
infusing the CCR5-down-modulated memory CD4 T-cells, the central memory and
memory stem cells had an essential role in this reconstitution.
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Moreover, in Chapter 5, our MCMC simulations have shown a great agreement
with the empirical data measurements which indicate the model and the parameter
estimation obtained using Monolix describes to a good extent the dynamics of the
CD4 T-cell in chronically infected HIV patients. This validates the conclusions
we obtained in chapter 4 about the importance of some of the na¨ıve and memory
CD4 T-cell populations. Further more, the stochastic fluctuations were shown to
successfully capture all the experimental data points.
6.0.1 Future Work
As this work showed that the na¨ıve, memory stem cell and central memory cell
played an important role in the CD4 T-cell reconstitution, future work could focus
on further investigating these types of CD4 T-cell. Moreover, as an extension for
this work, we can include the integrated viral DNA in our CD4 T-cell dynamical
model. This will allow us to further understand the HIV reservoir in the nine patient
so we are able to better understand the change in behavior for these sub-populations
after the initiation of the treatment. In this work we considered a linear CD4 T-cell
model. However, it was shown that backward transitions between the memory stem,
central and transitional memory cells is possible. This might be able to help us
get a more realistic insight about the real dynamics of the CD4 T-cell and the
virus in chronically infected HIV patients. This step is our future direction to
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further elaborate on in collaboration with Dr. Sekaly et al. Laboratory at Case
Western University. Moreover, when fitting the data, we have faced several issues
that affected the goodness of our results. We are planning to elaborate on this area
considering the following issues, with possible collaboration with Dr. Giles Hooker
at Cornell University.
• Allow some backward transition between the memory stem , central, transi-
tional and effector memory cells. This will allow us to capture hidden dynamics
that the current model was not able to do so. This issue was evident when
trying to estimate some of the proliferation and transition rates for these cells
in most of the patients.
• Perform a multiple imputation to better deal with the missing points.
• Have more observations per cell population for all of the three cohorts.
• Consider a hierarchical mixed approach allowing us to better understand
variability within and between individuals to better understand the effect of
injecting CCR5-down-modulated memory CD4 T-cell on the three different
cohorts.
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7 Appendix
Appendix A
Monolix: SEAM Algorithm- A Simulated Annealing version
This section is a summary of the algorithm presented in (Lavielle, 2015) [50].
The Stochastic approximation expectation-maximization also known as the
SEAM which computes an estimate to maximum likelihood (ML).It is divided into
two simulation stages:
1. The first stage is to get a neighboring solution through only few iteration from the
initial values that was given by the user in the software. In this stage a simulated
annealing is preferred to be used in to reduce the simulation time if the given initial
values are far from the real solution.
2. The second stage is when the occurrence of the convergence to the located
maximum in a deterministic behavior similar to the gradient algorithm.
Before presenting the SEAM algorithm it is important to describe the EM algorithm
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that is used in the SEAM algorithm.
First we will consider a general model where we have a vector of parameters θ, set
of observations y= yi, unobserved parameters sets z = zi, where 1 6 i 6 N and z
is normally distributed. The maximum likelihood estimator of θ is given by the
following formula:
Ly(θ) = p(y; θ) =
∫
p(y, z; θ)dz (7.1)
with p(y,z;θ) being the joint distribution.
As zi is unobserved, the EM algorithm replaces it by its conditional expectation,
where θEMk−1 gets updates at each iteration step k to θ
EM
k−1 given an initial value θ0 by
the following steps:
• E-step Where the expectation is evaluated by :
QEMk (θ) = E(logp(y, z : θ)|y; θEMk−1) (7.2)
• M-step In this step the expectation calculated in the E-step is maximized:
θEMk = argθmaxQ
EM
k (θ). (7.3)
As we are dealing with a non linear mixed effect model, the expectation cannot
be quantified explicitly using the EM algorithm as the observations y and the
parameters z are nonlinear. However, this problem can be solved by using a Monte
Carlo approximation using a large number of independent simulations of z. In the
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SEAM algorithm a single simulation of z is used.
The iterative steps of the SEAM algorithm are:
• The simulation step For i= 1....N, draw zki from the conditional distribution
given by p(zi| yi;θk−1), where zi are the individual parameters, yi are the obser-
vations given by a data set. Monolix uses a Hasting Metropolis-Hastings(MH)
algorithm to simulate the individual parameters with a limiting distribution
p(zi|;µk−1, ωk−1).
• Stochastic Approximation In this step will updateQk in the following way:
Qk = Qk−1 + γk(logp(y, zk; θ) (7.4)
such that γk being a decreasing sequence of positive numbers with γ1=1.This
indicates that the stochastic approximation has no memory of previous ap-
proximations.
• Maximization step In this step we will update θk − 1 using the M-step in
the EM algorithm where:
θk = argθmaxQk(θ) (7.5)
Calculation of the Fisher Information Matrix
The observed Fisher Information Matrix also known as FIM, is defined as the
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measurement of the amount of information that an observable random variable posses
about an unknown parameter which depends on a specific probability distribution.
it is expressed as a function of θ where :
Iy(θ) = −∂2θLLy(θ) (7.6)
Where LLy is the log-likelihood defined in equation 2.1 as :
LLy = l(y; θ) = log(p(y; θ)). (7.7)
As it was mentioned above, due to the complexity of some models, the likelihood
does not have a closed from solution which often suggests that the observed FIM
cannot have a closed form solution either. Hence it will be approximated using the
following methods:
• Stochastic approximation Using a Monte Carlo procedure based on Louis’
formula(louis 1982), Kuhn and Lavielle estimated the FIM using the following
formula:
∂2θ l(y; θ) = E(∂
2l(y, z, θ)|y; θ) + cov(∂θl(y, z, θ)|y; θ)) (7.8)
Where:
∂2θ l(y;θ) is the conditional expectation that is calculated using an MH Monte
Carlo method.
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cov(∂θ l (y,z,θ)|y; θ))= E((∂θ l(y,z;θ))(∂θl(y,z;θ))t|y; θ) -E((∂θ l(y,z;θ))|y; θ) E
((∂θ l(y,z;θ))|y; θ)t
In here it is important to mention that the MH algorithm used for the SEAM,
the sequence of estimated parameters θk is remained fix at the estimated
maximum likelihood θˆ.
• Model Linearization Consider the following model:
yij = f(tij, zi) + g(tij, zi)ij (7.9)
Where f is the structural model, g is the residual error model and i is the
standardized residual error.
In this fit, we have used a constant error model (in both the stochastic and
linearization methods) g= a so
yi = fj + aj (7.10)
The error model selection was based on the BIC and AIC information. The
model is linearized around the predicted vector of parameters z˜i in the following
way:
yij = f(tij, z˜i) + ∂zf(tij, z˜i)(zi − z˜i) + g(tij, z˜i)ij (7.11)
= f(tij, z˜i) + ∂zf(tij, z˜i)(zpop − z˜i) + g(tij, z˜i)ij + ∂zf(tij, z˜i)ηi.
216
Where the marginal distribution of the observation vector defined as yij
is approximated using a Normal Distribution with the following mean and
standard deviation:
µi = f(ti, z˜i) + ∂zf(ti, z˜i)(zpop − z˜i) (7.12)
Γ = ∂zf(ti, z˜i)ω∂zf(ti, z˜i)
t + g(ti, z˜i)Σig(ti, z˜i)
t (7.13)
The model selection is based on the Bayesian Information Criterion also known as
the BIC where a minimum BIC indicates a better model if the BIC is defined as:
BIC = −2LLy(zˆ) + log(n)d. (7.14)
Where n is the number of observation and d is the dimension.
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Appendix B
Stan Fit
This is based on a communication from Georges Monette (2015), the author of this
section.
Six fitted models
Working out a model using linearization as suggested by Giles Hooker(2015) has
been very helpful in clearly revealing the large differences in information available
for different portions of the parameter space. We will refer to the five types of cells
by number: 1, 2,..,5. The model has 15 independent parameters.
• λi the rate of autonomous production (per microlitre) of type 1, (Naive cells).
• τi i=1..4, the probability per day that a cell of type transforms into a cell of
type I+1.
• δi i=1..5, the probability per day of death for a cell of type i.
• βi i=1..5, the probability per day that a cell of type replicates.
let θi denote the net depletion probability per day for a cell of type i :
θi = δi+τi - βi, i= 1..4
θ5= δ5- β5
The stationary expectation for the density per microlitre of each type of cell is:
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µ1 =
λ
θ1
µ2 =
λτ1
θ1θ2
= µ1
τ1
θ2
µ3 =
λτ1τ2
θ1θ2θ3
= µ2
τ2
θ3
µ4 =
λτ1τ2τ3
θ1θ2θ3θ4
= µ3
τ3
θ4
µ5 =
λτ1τ2τ3τ4
θ1θ2θ3θ4θ5
= µ4
τ4
θ5
Let the sampling volume be n microlitres and the sampling fraction φ= n
V
,
where V is the total body blood volume in microlitres (approximately 5 litres).
Different transformations of the 15 dimensional parameter space are estimable
with very different orders of precision. The transformations for which there is the
most information are those that are functions of µi i=1..5. For example, the µ
′s
themselves or the four ratios: ρi =
µi+1
µi
= τi
θi+1
, i=1..4.
The variance of estimates of µi is approximately
µi
n
for a stable process.
The next set of parameter functions is that involving θi, or, combining θi with
µi, e.g :λ and τi. The relative variances of estimators of these parameters compared
with µ is φ−1, considerably larger than those for µ. Thus the standard errors would
be in the order of 2000 times greater. There is an intuitive explanation for this. Let
Yt1 and Yt2 represent vectors in R
5 consisting of the total body cell counts at two
times t1 and t2. Let Xt1 and Xt2 be the vectors of densities per microliter obtained
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by counting cells in a sample of n microlitres at each time if we could observe Yt1
and Yt1 . The stationary expectation of Yt1 and Yt2 and would allow us to estimate
µ with considerable precision. The exact precision depends on the parameters and
would be smaller if the process is close to the stationary boundary. For a relatively
stable process the precision is relatively large with standard error of the order
√
u
u
.
The distribution of Yt1 given Yt2 would provide information with a similar order
of precision on θ and observing additional values of provides information on the
conditional variance of the process which allows the separate identification of δ and
β with a lower precision than that available for µ and θ. However, with our data we
don’t have the full body cell count available but only samples assumed to be well
mixed Poisson samples.
Assuming a stable process, the variance of a relatively small sample will be
primarily due to sampling and the variance of estimates of µi will be approximately
µi
n
. To estimate the θi parameters we need to use the conditional distribution from
one time to the next. We would have a good estimate of θi from Yt1 and Yt2 but,
using Xt1 and Xt2 instead introduces variance in both the response and the predictor
of the conditional distribution. The result is to increase variance by a factor of φ−1
relative to the variance for the estimation of µ. Finally there is less information
(with relative variance of order greater than φ−2) for βi versus δi, i.e. estimating the
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separate contributions to depletion contritubed by the partly cancelling components
of birth versus death. Altogether, this means that, assuming the model is valid,
different values in the full 15 dimensional parameter space will produce dynamics for
the full body cell counts whose sample would be substantially equivalent to those
observed, as long as the µ parameters of the 15 dimensional parameters are similar.
One can generate sets of nearly equivalent parameters by inverting the transforma-
tion from the 15 dimensional parameter space to µ . Taking estimated values of µ ,
one can first choose a range of reasonable values for θ which leads to values for λ
and τ .
λ= θi µi.
τ1=
φi+1µi+1
µi
= ρi i =1..4.
From:
θi = δi + τi - βi , i=1..4
θ5 = δ5 - β5
We see that the θ and τ determine the net death rate:
δi- βi = vi= θi-τi
δ5- β5 = v5= θ5
Since δi ≥ 0, and βi ≥ 0 and since the variance of the population process is
monotonic in δi + βi , the choice of δi and βi that satisfies non-negativity and
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minimizes variance of the population process is :
δi = vi and βi = 0, if v1 ≤ 0,
δi = 0 and βi = - vi, if v1 ≥ 0,
The remaining 5 degrees of freedom allow adding the same quantity to both
δ and β. This does not affect marginal expectations but increases the marginal
variance. Letting αi ≥ 0, i=1..5 denote the additional quantity, we have:
δi = αi + vi , βi= αi, if vi > 0
δi = αi , βi= αi- vi, if vi ≤ 0
The parameters µ1 and ρi are estimated using MCMC and using a selection
of values for θi (0.01, 0.05 and 0.10) and α1 (0.0 and 0.1). The tables show the
distribution between individuals with means mu1 − mean, ratio − mean[i] and
standard deviations mu1 − sd and ratio − sd[i]. Also shown are the individual
estimates for λ, birth[i], death[i] and tran[i], as well as an estimate pop-var which
is an estimate of the population variation contribution to variance. In every case
pop-var is verified to be very small in comparison with sampling variance. The
model also uses a parameter for overdispersion: to what extent is the observed
variance smaller or larger than expected if the true sampling volume is 1 microlitre.
The estimate of the parameter is close to 0.10 which has a number of possible
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interpretations that are not mutually exclusive:
• the effective sample count might be based on less than a microlitre, e.g. 0.1
microlitres
• the model is inadequate on the variation from time to time does not reflect a
relatively stable state of the model
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